No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1romA_, 1.0000, 0.00, 1.000, 399, 399, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM
2, d2romA_, 0.9989, 0.24, 1.000, 399, 399, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM COMPLEX WITH CARBON MONOXIDE
3, d1geiA_, 0.9976, 0.36, 1.000, 399, 399, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
4, d5y5kB_, 0.9971, 0.39, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
5, d5y5lB_, 0.9970, 0.39, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
6, d5y5jB_, 0.9970, 0.40, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
7, d5y5iB_, 0.9970, 0.40, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
8, d1gejA_, 0.9969, 0.41, 1.000, 399, 399, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
9, d1jfcA_, 0.9968, 0.41, 1.000, 399, 399, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERROUS CO STATE AT ATOMIC RESOLUTION
10, d1f25A_, 0.9966, 0.42, 0.997, 399, 399, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ASN MUTANTS OF CYTOCHROME P450NOR
11, d5y5lA_, 0.9965, 0.43, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
12, d5y5kA_, 0.9965, 0.43, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
13, d5y5jA_, 0.9964, 0.44, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
14, d5y5iA_, 0.9964, 0.44, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
15, d1eheA_, 0.9964, 0.44, 1.000, 399, 399, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
16, d1jfbA_, 0.9963, 0.44, 1.000, 399, 399, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERRIC RESTING STATE AT ATOMIC RESOLUTION
17, d1cl6A_, 0.9963, 0.44, 1.000, 399, 399, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND ITS SER286 MUTANTS AT CRYOGENIC TEMPERATURE
18, d1f24A_, 0.9962, 0.45, 0.997, 399, 399, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ALA MUTANTS OF CYTOCHROME P450NOR
19, d1f26A_, 0.9961, 0.45, 0.997, 399, 399, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243VAL MUTANTS OF CYTOCHROME P450NOR
20, d1cmnA_, 0.9960, 0.46, 0.997, 399, 399, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
21, d5y5hA_, 0.9959, 0.46, 1.000, 400, 399, SF-ROX STRUCTURE OF CYTOCHROME P450NOR (NO-BOUND STATE) DETERMINED AT SACLA
22, d1cmjA_, 0.9959, 0.47, 0.997, 399, 399, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
23, d5y5gA_, 0.9957, 0.48, 1.000, 400, 399, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
24, d1ehfA_, 0.9957, 0.48, 1.000, 400, 399, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
25, d1ehgA_, 0.9954, 0.48, 0.997, 399, 399, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
26, d1ulwA_, 0.9948, 0.49, 0.997, 399, 399, CRYSTAL STRUCTURE OF P450NOR SER73GLY/SER75GLY MUTANT
27, d1gedA_, 0.9947, 0.52, 0.995, 399, 399, A POSITIVE CHARGE ROUTE FOR THE ACCESS OF NADH TO HEME FORMED IN THE DISTAL HEME POCKET OF CYTOCHROME P450NOR
28, d5y5fA_, 0.9935, 0.53, 1.000, 399, 399, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
29, d1xqdA_, 0.9662, 0.46, 1.000, 399, 398, CRYSTAL STRUCTURE OF P450NOR COMPLEXED WITH 3- PYRIDINEALDEHYDE ADENINE DINUCLEOTIDE
30, d5y1iB_, 0.9465, 1.52, 0.992, 399, 399, THE CRYSTAL STRUCTURE OF GFSF
31, d2z36A1, 0.9393, 1.36, 0.370, 394, 389, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
32, d2z36B1, 0.9371, 1.36, 0.370, 394, 389, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
33, d5y1iA_, 0.9345, 1.73, 0.365, 398, 394, THE CRYSTAL STRUCTURE OF GFSF
34, d3tywC1, 0.9257, 1.78, 0.365, 399, 394, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
35, d3tywD1, 0.9253, 1.78, 0.365, 399, 394, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
36, d3tywA1, 0.9225, 1.43, 0.369, 388, 385, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
37, d3tywB1, 0.9223, 1.93, 0.331, 395, 393, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
38, d5x7eA1, 0.9217, 1.94, 0.331, 395, 393, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D2
39, d2zbzA1, 0.9215, 2.00, 0.331, 395, 393, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D3
40, d3cv8A1, 0.9211, 2.00, 0.331, 395, 393, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84F MUTANT)
41, d2zbyA1, 0.9203, 2.01, 0.331, 395, 393, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT)
42, d3cv9A1, 0.9170, 2.12, 0.369, 403, 393, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R73A/R84A MUTANT) IN COMPLEX WITH 1ALPHA25- DIHYDROXYVITAMIN D3
43, d3e5lA1, 0.9127, 2.10, 0.369, 403, 393, CRYSTAL STRUCTURE OF CYP105P1 H72A MUTANT
44, d4ubsA_, 0.9119, 2.10, 0.369, 403, 393, THE CRYSTAL STRUCTURE OF CYTOCHROME P450 105D7 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH DICLOFENAC
45, d2zbxA1, 0.9088, 2.11, 0.369, 400, 393, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (WILD TYPE) WITH IMIDAZOLE BOUND
46, d4xe3B_, 0.9073, 2.11, 0.369, 399, 393, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
47, d2dkkA1, 0.9043, 2.19, 0.366, 399, 393, STRUCTURE/FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
48, d2nz5A1, 0.9036, 2.21, 0.343, 393, 391, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
49, d2nzaA1, 0.9031, 2.18, 0.365, 393, 392, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
50, d3zsnC_, 0.9023, 2.16, 0.373, 395, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
51, d3zsnB_, 0.9021, 2.17, 0.321, 394, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
52, d3zsnA_, 0.9020, 2.17, 0.257, 395, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
53, d3tzoB1, 0.9020, 2.18, 0.257, 395, 389, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
54, d5de9B1, 0.9017, 2.19, 0.257, 395, 389, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
55, d2y46C_, 0.9017, 2.29, 0.308, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
56, d2nz5B1, 0.9016, 2.30, 0.308, 393, 389, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
57, d2y46B_, 0.9015, 2.30, 0.308, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
58, d4xe3A_, 0.9014, 2.21, 0.272, 400, 389, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
59, d2y46A_, 0.9014, 2.21, 0.272, 400, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
60, d2y5zC_, 0.9013, 2.30, 0.308, 393, 389, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
61, d2y5zB_, 0.9013, 2.22, 0.257, 395, 389, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
62, d2y5nA_, 0.9013, 2.31, 0.308, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
63, d2y5zA_, 0.9012, 2.27, 0.319, 394, 389, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
64, d4fxbA_, 0.8999, 2.31, 0.308, 393, 389, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
65, d2ygxD_, 0.8999, 2.30, 0.308, 394, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
66, d2ygxB_, 0.8997, 2.30, 0.308, 394, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
67, d2y98A_, 0.8996, 2.33, 0.308, 394, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN P21212 SPACE GROUP
68, d4mm0A_, 0.8995, 2.30, 0.308, 393, 389, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
69, d4aw3B_, 0.8993, 2.27, 0.328, 390, 390, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
70, p5mnvH_, 0.8986, 2.29, 0.307, 393, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
71, d5foiA1, 0.8983, 2.30, 0.307, 393, 388, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
72, d2ygxA_, 0.8983, 2.34, 0.306, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
73, d2y5nB1, 0.8983, 2.25, 0.302, 392, 388, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
74, d5foiB_, 0.8980, 2.36, 0.308, 393, 389, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
75, d2ygxC_, 0.8980, 2.39, 0.315, 395, 390, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
76, p4oqsA_, 0.8979, 2.27, 0.296, 388, 385, CRYSTAL STRUCTURE OF CYP105AS1
77, d2ycaA_, 0.8979, 2.27, 0.296, 388, 385, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN P21212 SPACE GROUP
78, d4mm0B_, 0.8976, 2.31, 0.307, 393, 388, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
79, d5de9A1, 0.8975, 2.36, 0.308, 397, 389, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
80, d4aw3A_, 0.8970, 2.36, 0.308, 397, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
81, d3tzoA1, 0.8967, 2.28, 0.296, 388, 385, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
82, d5it1C_, 0.8963, 2.32, 0.307, 393, 388, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
83, d5it1B_, 0.8961, 1.83, 0.349, 384, 378, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
84, d5it1D_, 0.8959, 1.83, 0.349, 384, 378, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
85, d5it1A_, 0.8958, 2.33, 0.307, 393, 388, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
86, d4wq0A_, 0.8949, 2.26, 0.302, 394, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH OLIGOMYCIN A
87, d1se6B1, 0.8939, 2.26, 0.302, 394, 388, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
88, d3abaA1, 0.8922, 2.29, 0.272, 400, 389, CRYSTAL STRUCTURE OF CYP105P1 IN COMPLEX WITH FILIPIN I
89, d4z5pB_, 0.8920, 2.38, 0.308, 393, 389, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
90, d4z5pA_, 0.8910, 2.30, 0.275, 400, 389, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
91, p5mnvA_, 0.8909, 2.44, 0.357, 395, 387, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
92, d3e5kA1, 0.8889, 2.44, 0.357, 395, 387, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE 4-PHENYLIMIDAZOLE COMPLEX
93, d2d0eA1, 0.8882, 2.44, 0.357, 395, 387, SUBSTRATE ASSITED IN OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
94, d4wpzA_, 0.8861, 2.44, 0.357, 395, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS
95, d2d09A1, 0.8860, 2.44, 0.357, 395, 387, A ROLE FOR ACTIVE SITE WATER MOLECULES AND HYDROXYL GROUPS OF SUBSTRATE FOR OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
96, d1gwiA_, 0.8857, 2.51, 0.307, 397, 388, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
97, p5mnsA_, 0.8840, 2.51, 0.307, 397, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
98, p5mnsB_, 0.8839, 2.40, 0.272, 400, 390, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
99, d2nzaB1, 0.8837, 2.68, 0.343, 393, 391, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
100, p5mnvB_, 0.8834, 2.33, 0.306, 388, 385, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
101, d2wm4A_, 0.8831, 2.35, 0.306, 388, 385, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124 IN COMPLEX WITH PHYTANIC ACID
102, d1t93A1, 0.8827, 2.35, 0.306, 388, 385, EVIDENCE FOR MULTIPLE SUBSTRATE RECOGNITION AND MOLECULAR MECHANISM OF C-C REACTION BY CYTOCHROME P450 CYP158A2 FROM STREPTOMYCES COELICOLOR A3(2)
103, d3e5jA1, 0.8821, 2.52, 0.313, 397, 390, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE LIGAND-FREE FORM
104, d2x5wA_, 0.8817, 2.52, 0.313, 397, 390, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH SUBSTRATE CHOLEST-4-EN-3-ONE
105, d1gwiB_, 0.8817, 2.19, 0.342, 380, 380, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
106, d3abbA1, 0.8811, 2.61, 0.274, 401, 390, CRYSTAL STRUCTURE OF CYP105D6
107, d1s1fA1, 0.8802, 2.33, 0.304, 386, 382, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
108, p4l0fA_, 0.8783, 2.63, 0.274, 401, 390, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (OPEN ACTIVE SITE)
109, d5l1uA_, 0.8780, 2.70, 0.258, 402, 391, X-RAY STRUCTURE OF M81A MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
110, d4fxbB_, 0.8780, 2.64, 0.320, 395, 388, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
111, d5l1pA_, 0.8779, 2.64, 0.320, 395, 388, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE
112, d5l1sA_, 0.8778, 2.19, 0.260, 386, 381, X-RAY STRUCTURE OF F232L MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
113, d5l1vA_, 0.8777, 2.64, 0.320, 394, 388, X-RAY STRUCTURE OF M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
114, d5l1qA_, 0.8777, 2.60, 0.266, 426, 387, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH DIHYDROPENTALENOLACTONE F
115, d5l1oA_, 0.8777, 2.60, 0.266, 426, 387, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
116, d5l1tA_, 0.8772, 2.69, 0.274, 401, 390, X-RAY STRUCTURE OF M77S MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
117, d5l1rA_, 0.8771, 2.69, 0.274, 401, 390, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PNTM
118, d5l1wA_, 0.8762, 2.76, 0.339, 389, 386, X-RAY STRUCTURE OF 2-MERCAPTOETHANOL MODIFIED M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
119, d2bvjB_, 0.8761, 2.55, 0.260, 409, 385, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
120, d3o1aA_, 0.8756, 2.77, 0.258, 400, 391, STRUCTURE OF OXYE (CYP165D3) A CYTOCHROME P450 INVOLVED IN TEICOPLANIN BIOSYNTHESIS
121, p5mnsF_, 0.8749, 2.07, 0.379, 379, 377, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
122, d5uhuA_, 0.8742, 2.67, 0.273, 395, 388, SOLUTION CONFORMATION OF CYTOCHROME P450 MYCG WITH MYCINAMICIN IV BOUND
123, d2z3uA_, 0.8742, 2.63, 0.249, 437, 385, CRYSTAL STRUCTURE OF CHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
124, d1cptA_, 0.8729, 2.63, 0.249, 437, 385, CRYSTAL STRUCTURE AND REFINEMENT OF CYTOCHROME P450-TERP AT 2.3 ANGSTROMS RESOLUTION
125, d3a1lA_, 0.8721, 2.78, 0.288, 397, 389, CRYSTAL STRUCTURE OF 1111 -DICHLOROCHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
126, d4apyA_, 0.8712, 1.80, 0.330, 370, 370, ETHYLENE GLYCOL-BOUND FORM OF P450 CYP125A3 FROM MYCOBACTERIUM SMEGMATIS
127, d3iw0A_, 0.8711, 2.79, 0.288, 397, 389, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 C2221 CRYSTAL FORM
128, d4j6cB_, 0.8710, 2.79, 0.288, 397, 389, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
129, d4jbtB_, 0.8709, 2.86, 0.292, 397, 390, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
130, d4j6cA_, 0.8709, 2.86, 0.290, 397, 390, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
131, d5dqnA_, 0.8708, 2.79, 0.288, 397, 389, POLYETHYLENE 600-BOUND FORM OF P450 CYP125A3 MUTANT FROM MYOBACTERIUM SMEGMATIS - W83Y
132, d4jbtA_, 0.8707, 2.79, 0.288, 397, 389, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
133, d4j6bB_, 0.8704, 2.80, 0.288, 397, 389, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
134, d4j6bA_, 0.8696, 2.87, 0.292, 397, 390, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
135, d4j6dB_, 0.8694, 2.91, 0.287, 396, 390, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
136, d4j6dA_, 0.8694, 2.48, 0.290, 391, 383, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
137, d5gnmC_, 0.8687, 2.37, 0.257, 383, 377, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
138, d3a4hA_, 0.8685, 2.37, 0.257, 383, 377, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (ORTHORHOMBIC CRYSTAL FORM)
139, d5gnmD_, 0.8682, 2.71, 0.319, 393, 386, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
140, d2x5lA_, 0.8680, 2.71, 0.312, 393, 388, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 ALTERNATIVE CRYSTAL FORM
141, p5mnvG_, 0.8678, 2.86, 0.268, 411, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
142, d3p3xA_, 0.8674, 2.86, 0.268, 411, 388, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
143, d2wm5A_, 0.8674, 2.79, 0.264, 412, 387, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124
144, d2wi9B_, 0.8669, 2.79, 0.264, 412, 387, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
145, d3p3xB_, 0.8665, 2.93, 0.265, 411, 388, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
146, d5gnmB_, 0.8655, 2.68, 0.278, 414, 385, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
147, d3oo3A_, 0.8652, 2.69, 0.262, 407, 385, CRYSTAL STRUCTURE OF THE ORF6* (CYP165D3) MONOOXYGENASE INVOLVED IN TEICOPLANIN BIOSYNTHESIS
148, d1eh0A_, 0.8648, 3.06, 0.244, 406, 394,  
149, d5gnmA_, 0.8645, 3.06, 0.244, 407, 394, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
150, d1eupA_, 0.8645, 3.06, 0.244, 407, 394, X-RAY CRYSTAL STRUCTURE OF CYTOCHROME P450ERYF WITH ANDROSTENDIONE BOUND
151, d4umzB_, 0.8643, 3.06, 0.244, 407, 394, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
152, d4jx1B_, 0.8643, 2.61, 0.279, 410, 384, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
153, d4pxhA_, 0.8642, 3.06, 0.244, 407, 394, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
154, d4bf4P_, 0.8637, 3.01, 0.244, 405, 393, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
155, d3p3lA_, 0.8637, 2.96, 0.245, 405, 392, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
156, d4umzA_, 0.8635, 3.03, 0.244, 406, 393, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
157, d4jwuA_, 0.8635, 3.03, 0.244, 406, 393, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
158, d1oxaA_, 0.8629, 2.71, 0.325, 401, 381, CYTOCHROME P450 (DONOR:O2 OXIDOREDUCTASE)
159, d1odoA_, 0.8626, 2.72, 0.323, 400, 381, 1.85 A STRUCTURE OF CYP154A1 FROM STREPTOMYCES COELICOLOR A3(2)
160, d1egyA_, 0.8626, 2.76, 0.325, 401, 382, CYTOCHROME P450ERYF WITH 9-AMINOPHENANTHRENE BOUND
161, d4pxhE_, 0.8622, 2.73, 0.262, 414, 385, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
162, d4jx1A_, 0.8621, 2.73, 0.262, 414, 385, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
163, d3p3lB_, 0.8621, 2.27, 0.322, 380, 376, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
164, d4bf4O_, 0.8620, 2.74, 0.257, 397, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
165, d3p3zA1, 0.8620, 2.82, 0.273, 425, 385, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH FROM STREPTOMYCES THIOLUTEUS IN COMPLEX WITH ANCYMIDOL
166, d2uuqA_, 0.8620, 2.87, 0.288, 394, 389, CRYSTAL STRUCTURE OF CYP130 FROM MYCOBACTERIUM TUBERCULOSIS IN THE LIGAND-FREE FORM
167, d3w9cA_, 0.8619, 2.75, 0.257, 399, 381, CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
168, d2vzmB_, 0.8619, 2.74, 0.325, 399, 381, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
169, d2wi9A_, 0.8617, 2.07, 0.263, 371, 369, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
170, d1k2oA_, 0.8615, 2.89, 0.301, 403, 385, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
171, d5gxgA_, 0.8614, 2.69, 0.326, 399, 380, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
172, d3mgxB_, 0.8613, 2.90, 0.301, 403, 385, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
173, d2xn8A_, 0.8613, 2.92, 0.290, 395, 389, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125
174, d1jioA_, 0.8613, 2.46, 0.222, 405, 378, P450ERYF/6DEB
175, d1qmqA_, 0.8611, 2.77, 0.253, 417, 383, OPTICAL DETECTION OF CYTOCHROME P450 BY SENSITIZER-LINKED SUBSTRATES
176, d4yzrA_, 0.8609, 2.96, 0.288, 396, 389, BACILLUS SUBTILIS 168 BACILLAENE POLYKETIDE SYNTHASE (PKS) CYTOCHROME P450 PKSS
177, p6giiA_, 0.8608, 2.76, 0.266, 403, 380, THE CRYSTAL STRUCTURE OF TEPIDIPHILUS THERMOPHILUS P450 HEME DOMAIN 
178, p5nwsA_, 0.8608, 2.93, 0.290, 396, 389, CRYSTAL STRUCTURE OF SAACMM INVOLVED IN ACTINOMYCIN BIOSYNTHESIS
179, d1k2oB_, 0.8608, 2.47, 0.228, 405, 378, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
180, d2whfA_, 0.8605, 2.96, 0.301, 403, 386, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
181, d1se6A1, 0.8605, 3.02, 0.272, 395, 386, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
182, d2wgyA_, 0.8604, 3.02, 0.272, 395, 386, CRYSTAL STRUCTURE OF THE G243A MUTANT OF CYP130 FROM M. TUBERCULOSIS
183, d1jipA_, 0.8602, 2.96, 0.301, 403, 386, P450ERYF(A245S)/KETOCONAZOLE
184, d5cjeA_, 0.8600, 2.96, 0.301, 403, 386, STRUCTURE OF CYP107L2
185, d1uedB_, 0.8600, 2.79, 0.253, 407, 383, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
186, d1jinA_, 0.8600, 2.49, 0.225, 405, 378, P450ERYF/KETOCONAZOLE
187, d2c6hA_, 0.8599, 2.79, 0.266, 403, 380, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
188, d1z8qA_, 0.8598, 2.96, 0.290, 397, 389, FERROUS DIOXYGEN COMPLEX OF THE A245T CYTOCHROME P450ERYF
189, d4jx1E_, 0.8596, 2.69, 0.262, 406, 378, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
190, d2vzmA_, 0.8596, 2.85, 0.245, 394, 384, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
191, d5ex6A_, 0.8595, 2.33, 0.225, 401, 374, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
192, d2whwB_, 0.8595, 2.94, 0.288, 394, 389, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
193, d2c6hB_, 0.8595, 2.96, 0.288, 396, 389, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
194, d5fygA_, 0.8594, 2.50, 0.222, 406, 378, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
195, d5cweA_, 0.8594, 2.33, 0.225, 401, 374, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
196, d3g5fA_, 0.8593, 2.71, 0.237, 391, 380, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
197, d5ofqD_, 0.8592, 2.71, 0.237, 391, 380, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
198, d5ofqA_, 0.8592, 2.69, 0.259, 409, 382, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
199, d4jx1F_, 0.8592, 3.00, 0.301, 403, 386, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
200, d3p6sA_, 0.8592, 2.50, 0.225, 406, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
201, d1uedA_, 0.8592, 2.83, 0.292, 388, 383, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
202, d5ibjA_, 0.8591, 2.83, 0.292, 388, 383, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 6
203, d2whwA_, 0.8590, 2.94, 0.203, 416, 384, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
204, d4ipwA_, 0.8589, 3.05, 0.273, 395, 385, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
205, d4bf4G_, 0.8589, 3.05, 0.273, 395, 385, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
206, d4g46A_, 0.8588, 2.60, 0.222, 406, 379, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-OXO-4567- TETRAHYDROBENZOFURAN-3-CARBOXYLATE
207, d3g5hA_, 0.8588, 2.88, 0.245, 394, 384, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
208, d5fygB_, 0.8587, 2.23, 0.275, 382, 371, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
209, d4ktkA_, 0.8587, 2.82, 0.248, 394, 383, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-4-(4-HYDROXYPHENYL)-1H-PYRAZOL-5-YL)BENZENE-13-DIOL
210, d4iq9A_, 0.8587, 3.05, 0.300, 403, 387, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
211, d4g48A_, 0.8587, 2.77, 0.311, 390, 380, STRUCTURE OF CYP121 IN COMPLEX WITH 4-(4-PHENOXY-1H-PYRAZOL-3-YL) BENZENE-13-DIOL
212, d5fyfA_, 0.8586, 2.38, 0.267, 391, 374, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
213, d4bf4N_, 0.8586, 3.01, 0.301, 403, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
214, d4bf4L_, 0.8586, 2.90, 0.293, 393, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
215, d3zk5B_, 0.8586, 3.11, 0.298, 403, 389, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
216, d3iw2A_, 0.8586, 2.53, 0.228, 405, 378, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ECONAZOLE
217, d4ktlA_, 0.8585, 2.97, 0.288, 395, 389, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-((4-HYDROXYPHENYL)AMINO)-1H-PYRAZOLE-45-DIYL)DIPHENOL
218, d4ipsA_, 0.8585, 2.70, 0.288, 386, 378, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
219, d2wh8A_, 0.8585, 3.01, 0.288, 393, 389, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
220, d1n40A_, 0.8585, 3.01, 0.290, 394, 389, ATOMIC STRUCTURE OF CYP121 A MYCOBACTERIAL P450
221, p5wp2A_, 0.8584, 2.81, 0.256, 422, 383, 1.44 ANGSTROM CRYSTAL STRUCTURE OF CYP121 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH SUBSTRATE AND CN 
222, p5o4kA_, 0.8584, 2.81, 0.256, 422, 383, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6B.
223, d5ex6C_, 0.8584, 2.73, 0.310, 393, 378, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
224, d4g47A_, 0.8584, 2.99, 0.244, 394, 386, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-(1H-124- TRIAZOL-1-YL)PHENOL
225, d4g2gA_, 0.8584, 2.42, 0.272, 387, 372, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(1H-123-TRIAZOLE-15-DIYL)DIPHENOL
226, d3p6tA_, 0.8584, 2.42, 0.272, 387, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
227, d4g45A_, 0.8583, 2.45, 0.266, 386, 372, STRUCTURE OF CYTOCHROME CYP121 IN COMPLEX WITH 2-METHYLQUINOLIN-6- AMINE
228, d3zpiB_, 0.8582, 2.55, 0.225, 405, 378, PIKC D50N MUTANT IN P21 SPACE GROUP
229, d1q5eA_, 0.8582, 2.46, 0.229, 404, 376, SUBSTRATE-FREE CYTOCHROME P450EPOK
230, d5ibhA_, 0.8581, 2.55, 0.265, 391, 377, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26H
231, d4iq7A_, 0.8581, 2.55, 0.265, 391, 377, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
232, d4ictA_, 0.8581, 2.98, 0.246, 393, 386, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
233, d4bf4M_, 0.8581, 3.00, 0.290, 396, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
234, d4bf4B_, 0.8581, 2.99, 0.246, 394, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
235, d3mgxA_, 0.8581, 2.97, 0.286, 396, 388, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
236, p5op9A_, 0.8580, 3.00, 0.244, 394, 386, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7E
237, d5ibeA_, 0.8580, 2.99, 0.244, 394, 386, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25A
238, d1n4gA_, 0.8580, 2.85, 0.255, 419, 384, STRUCTURE OF CYP121 A MYCOBACTERIAL P450 IN COMPLEX WITH IODOPYRAZOLE
239, d4ktjA_, 0.8579, 2.99, 0.246, 394, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-1H-PYRAZOL-4-YL)PHENOL
240, d4g44A_, 0.8579, 3.00, 0.246, 394, 386, STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND MB286 3-((1H- 124-TRIAZOL-1-YL)METHYL)ANILINE
241, d4bf4D_, 0.8579, 2.99, 0.244, 394, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
242, d5ibdA_, 0.8578, 2.82, 0.256, 420, 383, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 24A
243, d3rwlA_, 0.8578, 3.01, 0.290, 397, 389, STRUCTURE OF P450PYR HYDROXYLASE
244, d3cxvA_, 0.8578, 3.02, 0.290, 397, 389, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 A233G MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
245, d1rf9A_, 0.8578, 2.93, 0.293, 394, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-4-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-BUTYL-AMIDE)
246, p5opaA_, 0.8577, 2.57, 0.260, 398, 377, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7B
247, d5ibiA_, 0.8577, 3.00, 0.244, 394, 386, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26A
248, d3cxzA_, 0.8577, 3.00, 0.246, 394, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 R386L MUTANT FROM M. TUBERCULOSIS
249, d1z8oA_, 0.8577, 2.87, 0.253, 392, 383, FERROUS DIOXYGEN COMPLEX OF THE WILD-TYPE CYTOCHROME P450ERYF
250, d5cweB_, 0.8576, 3.00, 0.244, 394, 386, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
251, d4pxhC_, 0.8576, 3.00, 0.244, 394, 386, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
252, d4bf4A_, 0.8576, 2.99, 0.246, 394, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
253, d3cxxA_, 0.8576, 3.00, 0.244, 394, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 F338H FROM M. TUBERCULOSIS
254, d5ikiB_, 0.8575, 2.68, 0.291, 388, 378, CYP106A2 WITH SUBSTRATE ABIETIC ACID
255, d5edtA_, 0.8575, 3.00, 0.244, 394, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH LIG9
256, d4jwuB_, 0.8575, 3.00, 0.244, 394, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
257, d4b7dB_, 0.8575, 2.55, 0.225, 404, 378, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
258, d3cxyA_, 0.8575, 3.00, 0.244, 394, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 P346L MUTANT FROM M. TUBERCULOSIS
259, d3p6qA_, 0.8573, 2.93, 0.293, 396, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-ETG-BOC
260, d1pkfA_, 0.8573, 3.09, 0.225, 404, 387, CRYSTAL STRUCTURE OF EPOTHILONE D-BOUND CYTOCHROME P450EPOK
261, d2cd8B_, 0.8572, 3.09, 0.225, 404, 387, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
262, d4ktfA_, 0.8571, 3.00, 0.244, 393, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-AMINO-1H-PYRAZOLE-45-DIYL)DIPHENOL
263, d4g1xA_, 0.8571, 2.93, 0.247, 394, 385, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(1H-124-TRIAZOL-1-YL)QUINOLIN-6-AMINE
264, d3ivyA_, 0.8571, 2.93, 0.244, 394, 385, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 P212121 CRYSTAL FORM
265, d2wh8B_, 0.8571, 3.01, 0.286, 397, 388, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
266, d4b7sB_, 0.8570, 2.98, 0.286, 397, 388, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
267, d3iw1A_, 0.8570, 2.70, 0.235, 387, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ANDROSTENEDIONE
268, d3cy0A_, 0.8568, 3.00, 0.244, 394, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 S237A MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
269, d2xbkA_, 0.8568, 3.01, 0.244, 394, 386, X-RAY STRUCTURE OF THE SUBSTRATE-BOUND CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
270, d2ij5A_, 0.8568, 2.86, 0.240, 392, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
271, p5o4lA_, 0.8566, 3.01, 0.244, 394, 386, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6A.
272, d4bf4E_, 0.8566, 3.01, 0.244, 394, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
273, d2wh8C_, 0.8566, 3.02, 0.290, 397, 389, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
274, d2bvjA_, 0.8565, 3.00, 0.244, 394, 386, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
275, d5ibfA_, 0.8563, 2.91, 0.267, 404, 382, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 19A
276, d3cy1A_, 0.8562, 3.01, 0.241, 394, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 S279A MUTANT FROM M. TUBERCULOSIS
277, d2ij7A_, 0.8562, 2.55, 0.225, 404, 378, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
278, d2ca0A_, 0.8562, 3.01, 0.244, 393, 386, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
279, d4bf4F_, 0.8561, 3.01, 0.244, 393, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
280, d4bf4H_, 0.8560, 3.01, 0.244, 394, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
281, d1z8pA_, 0.8556, 3.14, 0.296, 402, 389, FERROUS DIOXYGEN COMPLEX OF THE A245S CYTOCHROME P450ERYF
282, d3tktA_, 0.8555, 2.76, 0.310, 393, 378, CRYSTAL STRUCTURE OF CYP108D1 FROM NOVOSPHINGOBIUM AROMATICIVORANS DSM12444
283, d5xjnA_, 0.8553, 2.87, 0.253, 409, 383, CYTOCHROME P450 CREJ IN COMPLEX WITH (4-ETHYLPHENYL) DIHYDROGEN PHOSPHATE
284, d2wh8D_, 0.8553, 3.02, 0.290, 396, 389, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
285, d3p3oA1, 0.8552, 3.01, 0.241, 394, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERMII) FROM STREPTOMYCES THIOLUTEUS
286, d1q5dA_, 0.8552, 2.95, 0.275, 399, 382, EPOTHILONE B-BOUND CYTOCHROME P450EPOK
287, d5ofqB_, 0.8549, 2.95, 0.275, 399, 382, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
288, d4bf4J_, 0.8549, 2.94, 0.244, 394, 385, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
289, d2ij7E_, 0.8549, 2.49, 0.231, 403, 376, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
290, d4tx3A_, 0.8548, 2.97, 0.295, 393, 386, COMPLEX OF THE X-DOMAIN AND OXYB FROM TEICOPLANIN BIOSYNTHESIS
291, d2yooB_, 0.8548, 3.01, 0.246, 393, 386, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
292, d5gnlA_, 0.8546, 2.51, 0.227, 401, 375, CYTOCHROME P450 VDH (CYP107BR1) F106V MUTANT
293, d2xc3A_, 0.8545, 2.94, 0.223, 403, 385, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP125 BOUND TO THE REVERSE TYPE I INHIBITOR
294, d2ij5B_, 0.8545, 2.98, 0.286, 392, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
295, d5ofqC_, 0.8542, 3.02, 0.244, 392, 386, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
296, d5hh3A_, 0.8542, 3.02, 0.244, 394, 386, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
297, d3p6uA_, 0.8542, 2.59, 0.257, 399, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C6-DANS
298, d3bujA1, 0.8542, 2.90, 0.248, 392, 383, CRYSTAL STRUCTURE OF CALO2
299, d2ij5C_, 0.8541, 3.02, 0.286, 393, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
300, d4bf4K_, 0.8540, 2.55, 0.258, 398, 376, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
301, d2yooC_, 0.8540, 2.95, 0.244, 394, 385, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
302, d2ij7B_, 0.8539, 3.09, 0.269, 391, 386, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
303, d5ex6B_, 0.8538, 3.09, 0.269, 391, 386, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
304, d2ij7D_, 0.8538, 3.01, 0.244, 392, 386, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
305, d5gweC_, 0.8536, 2.99, 0.242, 393, 385, CYTOCHROME P450 CREJ
306, d2c7xA_, 0.8536, 3.03, 0.288, 397, 389, CRYSTAL STRUCTURE OF NARBOMYCIN-BOUND CYTOCHROME P450 PIKC (CYP107L1)
307, d2ij7C_, 0.8535, 2.79, 0.255, 388, 381, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
308, d4bf4I_, 0.8533, 2.97, 0.293, 394, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
309, d3zpiA_, 0.8531, 3.02, 0.246, 393, 386, PIKC D50N MUTANT IN P21 SPACE GROUP
310, d5ibgA_, 0.8527, 3.03, 0.246, 394, 386, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25B
311, d2ij5D_, 0.8527, 2.98, 0.252, 391, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
312, d3a4gA_, 0.8526, 3.05, 0.290, 393, 389, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (TRIGONAL CRYSTAL FORM)
313, d5gweD_, 0.8525, 3.02, 0.286, 396, 388, CYTOCHROME P450 CREJ
314, d3zk5A_, 0.8525, 3.04, 0.288, 396, 389, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
315, d2ij7F_, 0.8525, 3.16, 0.296, 403, 389, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
316, d5gweA_, 0.8523, 3.06, 0.238, 411, 387, CYTOCHROME P450 CREJ
317, d4triB_, 0.8522, 3.06, 0.238, 411, 387, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
318, d4b7dA_, 0.8522, 3.21, 0.251, 403, 386, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
319, d5hdiA_, 0.8521, 2.93, 0.249, 389, 382, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
320, d2yooD_, 0.8520, 2.90, 0.262, 406, 378, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
321, d4b7sA_, 0.8519, 2.90, 0.262, 406, 378, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
322, d4dxyA_, 0.8518, 2.93, 0.224, 401, 384, CRYSTAL STRUCTURES OF CYP101D2 Y96A MUTANT
323, d3p6pA_, 0.8518, 2.51, 0.272, 386, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C6-BIO
324, d4triA1, 0.8515, 3.08, 0.288, 397, 389, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
325, d2cd8A_, 0.8515, 2.98, 0.252, 391, 385, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
326, d2yooA_, 0.8514, 2.53, 0.293, 373, 372, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
327, d4bf4C_, 0.8513, 2.71, 0.257, 395, 377, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
328, d3p6rA_, 0.8513, 2.94, 0.323, 395, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-ETG-BOC
329, d3ejbH_, 0.8503, 2.70, 0.261, 409, 379, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
330, d2ca0B_, 0.8503, 3.01, 0.244, 390, 385, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
331, d3p6wA_, 0.8500, 2.51, 0.272, 386, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-ETG-BOC
332, d3p6vA_, 0.8497, 2.58, 0.266, 381, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3ET-ADAC1-ETG-BOC
333, d3ol5A_, 0.8496, 2.50, 0.229, 402, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED WITH A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-C8-DANS
334, d4y8wA1, 0.8495, 2.90, 0.266, 396, 380, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
335, d5l90B1, 0.8494, 2.90, 0.266, 396, 380, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
336, d3vrmA_, 0.8492, 3.03, 0.246, 394, 386, STRUCTURE OF CYTOCHROME P450 VDH MUTANT T107A WITH BOUND VITAMIN D3
337, d3p6mA_, 0.8492, 3.08, 0.286, 397, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
338, d4y8wB1, 0.8486, 2.73, 0.257, 395, 377, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
339, d3p6nA_, 0.8485, 3.01, 0.252, 391, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
340, d3nv6A_, 0.8485, 2.32, 0.298, 371, 369, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D2
341, p5vbuB_, 0.8484, 3.01, 0.252, 391, 385, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
342, d2xkrA_, 0.8484, 3.29, 0.248, 405, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP142: A NOVEL CHOLESTEROL OXIDASE
343, d5vwsA_, 0.8482, 3.06, 0.286, 396, 388, LIGAND FREE STRUCTURE OF CYTOCHROME P450 TBTJ1
344, d2xfhA_, 0.8482, 3.00, 0.252, 391, 385, STRUCTURE OF CYTOCHROME P450 ERYK COCRYSTALLIZED WITH INHIBITOR CLOTRIMAZOLE.
345, d3p6oA_, 0.8481, 3.09, 0.284, 396, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-ETG-DANS
346, d3a51D_, 0.8480, 3.03, 0.290, 396, 386, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
347, d3wriB1, 0.8479, 2.92, 0.253, 390, 383, CRYSTAL STRUCTURE OF P450CAM
348, d3wriA1, 0.8479, 3.03, 0.249, 391, 385, CRYSTAL STRUCTURE OF P450CAM
349, d3a4zD_, 0.8479, 2.83, 0.327, 395, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
350, d3l62A_, 0.8478, 3.18, 0.249, 403, 385, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT LOW [K+]
351, d5h1zA_, 0.8477, 3.03, 0.290, 397, 386, CYP153D17 FROM SPHINGOMONAS SP. PAMC 26605
352, d3ejeD_, 0.8477, 3.03, 0.290, 397, 386, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
353, p5vbuC_, 0.8475, 3.03, 0.252, 391, 385, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
354, d1lwlA_, 0.8475, 3.31, 0.248, 405, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
355, d3a4zE_, 0.8474, 3.31, 0.248, 405, 387, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
356, d3a4zB_, 0.8473, 2.75, 0.257, 400, 377, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
357, d3oiaA_, 0.8472, 3.12, 0.290, 393, 389, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8GLUETG-BIO
358, d1re9A_, 0.8472, 2.78, 0.205, 397, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
359, p5vbuA_, 0.8471, 2.78, 0.205, 397, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
360, d4y8wC1, 0.8471, 2.69, 0.258, 394, 376, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
361, d3a50D_, 0.8469, 3.04, 0.293, 397, 386, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
362, d3a50B_, 0.8469, 2.67, 0.185, 406, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
363, d2ij5F_, 0.8469, 2.70, 0.222, 407, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
364, d3ejdD_, 0.8468, 2.77, 0.257, 397, 377, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
365, d3a51C_, 0.8468, 2.96, 0.289, 391, 384, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
366, d3a51B_, 0.8468, 2.78, 0.257, 396, 377, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
367, d5l91A1, 0.8467, 3.08, 0.286, 396, 388, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
368, d3ejbD_, 0.8466, 2.41, 0.229, 398, 371, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
369, d3a51E_, 0.8465, 3.09, 0.294, 387, 377, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
370, d3a4zC_, 0.8465, 3.09, 0.294, 387, 377, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
371, d3nv5A_, 0.8459, 3.05, 0.293, 393, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D2
372, d3a50E_, 0.8459, 2.49, 0.225, 400, 373, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
373, d2ij5E_, 0.8459, 2.42, 0.226, 398, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
374, d5l90A1, 0.8457, 2.74, 0.222, 405, 378, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
375, d3a50C_, 0.8457, 2.94, 0.173, 439, 382, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
376, d3ejdB_, 0.8456, 2.51, 0.287, 384, 369, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
377, d2z3tA_, 0.8455, 3.01, 0.323, 402, 378, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
378, d4yt3A_, 0.8452, 2.75, 0.222, 404, 378, CYP106A2
379, d4pwvA_, 0.8452, 2.99, 0.172, 439, 383, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
380, d4jwsB_, 0.8451, 2.76, 0.222, 404, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
381, d5fyfB_, 0.8450, 2.80, 0.182, 404, 380, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
382, d3p6xA_, 0.8450, 3.03, 0.175, 441, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C8-DANS
383, d5m0pB_, 0.8449, 2.80, 0.253, 395, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
384, d5hdiB_, 0.8447, 2.28, 0.288, 376, 365, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
385, d3qz1A_, 0.8446, 2.28, 0.288, 376, 365, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
386, d5m0nA1, 0.8445, 2.86, 0.277, 394, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET IN COMPLEX WITH FORMATE
387, d2uvnA1, 0.8445, 2.77, 0.222, 405, 378, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
388, d5l91B1, 0.8444, 3.10, 0.325, 402, 382, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
389, d4l54A_, 0.8444, 2.55, 0.225, 401, 374, STRUCTURE OF CYTOCHROME P450 OLET LIGAND-FREE
390, d3ejdH_, 0.8443, 2.55, 0.225, 401, 374, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
391, d5m0pA1, 0.8440, 3.11, 0.325, 401, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
392, d5m0oA_, 0.8440, 2.52, 0.223, 400, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
393, d3a50A_, 0.8438, 3.08, 0.254, 400, 382, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
394, d3r9bC_, 0.8435, 3.08, 0.254, 400, 382, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
395, d3a51A_, 0.8435, 2.97, 0.297, 385, 374, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
396, d4l40A_, 0.8434, 3.04, 0.175, 442, 383, STRUCTURE OF THE P450 OLET WITH A C20 FATTY ACID SUBSTRATE BOUND
397, d3r9bB_, 0.8434, 2.77, 0.222, 404, 378, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
398, d3r9bA_, 0.8434, 3.04, 0.325, 401, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
399, d1lg9A_, 0.8432, 3.05, 0.325, 402, 379, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
400, d3a4zA_, 0.8431, 2.78, 0.222, 405, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
401, d3ejeF_, 0.8426, 2.77, 0.222, 404, 378, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
402, d5m0oC1, 0.8425, 3.05, 0.175, 442, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
403, d5lieB_, 0.8425, 3.04, 0.175, 441, 383, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
404, d1lgfA_, 0.8425, 3.12, 0.325, 401, 382, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
405, d2z3tC_, 0.8423, 3.05, 0.325, 402, 379, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
406, d5ikiA_, 0.8422, 2.94, 0.247, 384, 380, CYP106A2 WITH SUBSTRATE ABIETIC ACID
407, d3ejeH_, 0.8422, 2.99, 0.297, 385, 374, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
408, p5omrA_, 0.8419, 3.19, 0.324, 401, 383, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH VANILLIN. 
409, d3ejdF_, 0.8419, 3.15, 0.325, 402, 382, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
410, p5omsA_, 0.8416, 2.78, 0.284, 388, 373, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAETHOL. 
411, d4yt3B_, 0.8412, 2.78, 0.284, 388, 373, CYP106A2
412, d2vrvA_, 0.8409, 3.15, 0.295, 386, 376,  
413, d3wecA_, 0.8408, 3.14, 0.325, 401, 382, STRUCTURE OF P450 RAUA (CYP1050A1) COMPLEXED WITH A BIOSYNTHETIC INTERMEDIATE OF AURACHIN RE
414, d5wk9A_, 0.8399, 3.14, 0.325, 401, 382, R186AP450CAM WITH CN AND CAMPHOR
415, d5wk7A_, 0.8398, 2.74, 0.183, 399, 377, P450CAM MUTANT R186A
416, d3qz1C_, 0.8395, 3.06, 0.325, 401, 379, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
417, d3qz1B_, 0.8395, 2.95, 0.242, 387, 380, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
418, d3ofuB_, 0.8395, 2.57, 0.287, 384, 369, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
419, d5ik1A_, 0.8394, 3.15, 0.325, 401, 382, OPEN STATE OF P450CAM AFTER SOAKING IN CAMPHOR
420, d3oftA_, 0.8394, 2.93, 0.298, 382, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
421, d3ejbB_, 0.8394, 2.79, 0.273, 385, 373, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
422, d1izoA_, 0.8394, 2.67, 0.277, 388, 372, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
423, d4ep6A_, 0.8393, 2.94, 0.253, 404, 379, CRYSTAL STRUCTURE OF THE XPLA HEME DOMAIN IN COMPLEX WITH IMIDAZOLE AND PEG
424, d4z5qA_, 0.8392, 2.48, 0.224, 395, 370, CRYSTAL STRUCTURE OF THE LNMZ CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.8 A RESOLUTION
425, d3qz1D_, 0.8390, 2.77, 0.261, 411, 376, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
426, d3ofuC_, 0.8389, 2.52, 0.231, 399, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
427, d3ejbF_, 0.8387, 2.97, 0.137, 421, 379, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
428, d3vtjA_, 0.8386, 2.75, 0.207, 393, 377, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245H
429, d3vooA_, 0.8386, 3.04, 0.147, 445, 381, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245E
430, d2fr7A_, 0.8386, 3.04, 0.147, 445, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP199A2
431, d3l61A_, 0.8385, 2.97, 0.137, 422, 379, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT 200 MM [K+]
432, d3awqA_, 0.8385, 2.97, 0.137, 422, 379, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT L78F
433, p2wivB_, 0.8385, 3.28, 0.246, 397, 386, CYTOCHROME-P450 XPLA HEME DOMAIN P21
434, d3vnoA_, 0.8383, 3.28, 0.246, 397, 386, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT R241E
435, d3ofuA_, 0.8383, 2.73, 0.285, 387, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
436, p2wiyA_, 0.8383, 2.98, 0.137, 419, 379, CYTOCHROME P450 XPLA HEME DOMAIN P21212
437, p2wivA_, 0.8383, 2.97, 0.298, 382, 372, CYTOCHROME-P450 XPLA HEME DOMAIN P21
438, d3vm4A_, 0.8381, 3.00, 0.137, 422, 379, CYTOCHROME P450SP ALPHA (CYP152B1) IN COMPLEX WITH (R)-IBUPROPHEN
439, d3ejeB_, 0.8379, 2.98, 0.137, 419, 379, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
440, d2wioA_, 0.8379, 3.07, 0.325, 402, 379, STRUCTURE OF THE  HISTIDINE TAGGED OPEN CYTOCHROME P450 ERYK FROM S. ERYTHRAEA
441, d3awpA_, 0.8375, 2.86, 0.267, 391, 375, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT F288G
442, d3awmA_, 0.8372, 3.18, 0.325, 402, 382, CYTOCHROME P450SP ALPHA (CYP152B1) WILD-TYPE WITH PALMITIC ACID
443, d2x80B_, 0.8371, 3.00, 0.137, 419, 379, P450 BM3 F87A IN COMPLEX WITH DMSO
444, d2jjoA_, 0.8370, 2.86, 0.267, 391, 375, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH ITS NATURAL SUBSTRATE ERD
445, d2zqxC_, 0.8368, 2.86, 0.267, 391, 375, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
446, d2uvnB_, 0.8368, 2.51, 0.271, 377, 369, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
447, d1izoC_, 0.8366, 3.19, 0.325, 402, 382, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
448, d3ofuD_, 0.8365, 3.19, 0.325, 402, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
449, d5hh3C1, 0.8363, 2.91, 0.300, 380, 370, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
450, d3ekbB_, 0.8363, 3.09, 0.139, 419, 380, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
451, d4ek1B_, 0.8361, 3.10, 0.277, 397, 379, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
452, d5l92A_, 0.8359, 3.10, 0.277, 397, 379, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
453, d2z3tD_, 0.8359, 3.11, 0.266, 388, 379, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
454, d2x80A_, 0.8358, 3.11, 0.266, 388, 379, P450 BM3 F87A IN COMPLEX WITH DMSO
455, d1dz8B_, 0.8357, 2.78, 0.275, 383, 371, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
456, d4l4gA_, 0.8356, 2.56, 0.276, 383, 369, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358P/K178G
457, d3oftB_, 0.8355, 3.01, 0.298, 383, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
458, d5gweB_, 0.8354, 2.89, 0.215, 403, 377, CYTOCHROME P450 CREJ
459, d2zqjC_, 0.8353, 2.97, 0.299, 381, 371, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
460, d2zqjB_, 0.8353, 2.89, 0.212, 403, 377, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
461, d4jwsA_, 0.8352, 2.71, 0.277, 388, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
462, d3l63A_, 0.8350, 2.98, 0.275, 391, 375, CRYSTAL STRUCTURE OF CAMPHOR-BOUND P450CAM AT LOW [K+]
463, d1dz9B_, 0.8350, 3.05, 0.243, 401, 379, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
464, d2zqxA_, 0.8349, 3.05, 0.243, 401, 379, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
465, d1t86A_, 0.8349, 2.83, 0.211, 405, 375, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
466, d1t87A_, 0.8348, 2.84, 0.213, 405, 375, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
467, d4l49A_, 0.8347, 2.98, 0.149, 437, 377, STRUCTURE OF L358A MUTANT OF P450CAM BOUND TO CAMPHOR
468, d2zqxB_, 0.8347, 2.83, 0.149, 436, 375, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
469, d2x9pA_, 0.8347, 2.89, 0.218, 396, 380, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
470, d1o76B_, 0.8347, 2.49, 0.226, 394, 367, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
471, d5l94A_, 0.8346, 2.90, 0.218, 396, 380, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
472, d2a1oA_, 0.8346, 2.90, 0.218, 396, 380, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
473, d2zqjA_, 0.8344, 2.78, 0.297, 380, 367, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
474, p2hi4A_, 0.8343, 2.99, 0.135, 411, 378, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 1A2 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
475, d3czhB1, 0.8342, 2.99, 0.135, 411, 378, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
476, d2gr6A_, 0.8342, 2.85, 0.219, 392, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
477, d1j51A_, 0.8342, 2.13, 0.299, 363, 358, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
478, d4l4fA_, 0.8340, 2.94, 0.149, 434, 377, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G/D182N
479, d3r9cA_, 0.8340, 2.90, 0.218, 396, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 WITH ECONAZOLE BOUND
480, d2a1mA_, 0.8340, 2.91, 0.299, 378, 368, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
481, d1uyuB_, 0.8340, 2.98, 0.114, 407, 378, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
482, d1izoB_, 0.8340, 2.98, 0.116, 407, 378, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
483, d1mpwA_, 0.8339, 2.80, 0.226, 397, 371, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
484, d4l4eA_, 0.8337, 2.53, 0.225, 396, 369, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G
485, d2a1nA_, 0.8337, 2.98, 0.116, 407, 378, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
486, d1dz6B_, 0.8337, 2.93, 0.224, 391, 375, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
487, d5li8A_, 0.8336, 2.99, 0.119, 407, 378, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH KETOCONAZOLE
488, d4l4dA_, 0.8336, 2.91, 0.218, 396, 380, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A
489, d3dl9B2, 0.8336, 2.92, 0.221, 394, 375, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
490, d1j51C_, 0.8336, 2.92, 0.221, 394, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
491, d2ojdB1, 0.8335, 2.91, 0.235, 391, 375,  
492, d1yqoB_, 0.8335, 2.99, 0.119, 407, 378, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
493, d1dz8A_, 0.8335, 2.87, 0.297, 378, 367, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
494, d3c6gB2, 0.8334, 2.97, 0.275, 393, 374, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
495, d3cp4A_, 0.8332, 3.00, 0.116, 407, 378, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
496, d1pheA_, 0.8332, 3.01, 0.116, 407, 378, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
497, d1dz9A_, 0.8332, 3.01, 0.116, 407, 378, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
498, d2gqxA_, 0.8331, 3.22, 0.126, 455, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
499, d1t85A_, 0.8331, 3.02, 0.271, 393, 373, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM MUTANT (L358P/C334A)
500, d1t88A_, 0.8329, 3.05, 0.138, 411, 378, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
501, d1bu7B_, 0.8329, 3.17, 0.250, 391, 380, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
502, d5jquB_, 0.8328, 3.03, 0.135, 411, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
503, d3kx5B_, 0.8328, 2.86, 0.220, 394, 378, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
504, d1iwkA_, 0.8328, 2.97, 0.272, 387, 375, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(112K) CYTOCHROME P450CAM
505, d5e7yB_, 0.8327, 2.97, 0.272, 387, 375, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
506, d4duaA_, 0.8327, 3.22, 0.121, 457, 380, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
507, d2h7qA_, 0.8327, 2.91, 0.219, 404, 375, CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
508, d1phcA_, 0.8327, 2.76, 0.280, 386, 368, CRYSTAL STRUCTURE OF SUBSTRATE-FREE PSEUDOMONAS PUTIDA CYTOCHROME P450
509, d6cppA_, 0.8326, 2.78, 0.277, 379, 368, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
510, d2jjnA_, 0.8326, 3.24, 0.123, 455, 381, STRUCTURE OF CLOSED CYTOCHROME P450 ERYK
511, d2feuB_, 0.8326, 2.93, 0.219, 405, 375, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
512, d1t86B_, 0.8326, 2.92, 0.219, 405, 375, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
513, d5l92B_, 0.8325, 2.85, 0.220, 393, 377, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
514, d2bmhB_, 0.8325, 3.29, 0.243, 396, 378, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
515, d1dz4B_, 0.8325, 2.99, 0.138, 411, 377, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
516, d2nnbB_, 0.8324, 3.04, 0.135, 411, 378, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
517, d5cp4A_, 0.8323, 2.48, 0.227, 392, 366, CRYOGENIC STRUCTURE OF P450CAM
518, d4ejhG_, 0.8323, 2.92, 0.216, 405, 375, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
519, d4dubA_, 0.8323, 2.94, 0.219, 405, 375, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
520, d3wrlA_, 0.8323, 3.01, 0.138, 411, 377, CRYSTAL STRUCTURE OF P450CAM
521, d2hpdB_, 0.8323, 2.93, 0.219, 406, 375, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
522, d2cp4A_, 0.8323, 2.94, 0.219, 407, 375, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
523, d4dufD_, 0.8321, 2.93, 0.219, 405, 375, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
524, d1og2A_, 0.8321, 3.05, 0.135, 411, 378, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
525, p6c94A_, 0.8320, 2.95, 0.277, 385, 376, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH THE INHIBITOR HET0016 
526, p6c93A_, 0.8320, 2.95, 0.219, 405, 375, EFFECTS OF THE E310A MUTATION OF CYTOCHROME P450 4B1 (CYP4B1) ON N- OCTANE BINDING AND HEME RUFFLING 
527, d4l4bA_, 0.8320, 2.81, 0.277, 385, 368, STRUCTURE OF L358A/K178G/D182N MUTANT OF P450CAM BOUND TO CAMPHOR
528, d4g3rA_, 0.8320, 2.95, 0.213, 405, 375, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
529, d1iwiA_, 0.8320, 3.02, 0.135, 411, 377, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM
530, d1fahB_, 0.8320, 3.19, 0.151, 480, 385, STRUCTURE OF CYTOCHROME P450
531, d4l4aA_, 0.8319, 3.19, 0.151, 480, 385, STRUCTURE OF L358A/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
532, d4kkyX_, 0.8319, 3.25, 0.143, 462, 385, CRYSTAL STRUCTURE OF N-(1-PYRENE)ACETAMIDE LABELED P450CAM IN SUBSTRATE BOUND FORM.
533, d4dufA_, 0.8319, 2.95, 0.211, 405, 375, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
534, d3wrhA_, 0.8319, 2.95, 0.216, 405, 375, CRYSTAL STRUCTURE OF P450CAM
535, d1phaA_, 0.8319, 2.96, 0.213, 405, 375, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
536, d1o76A_, 0.8319, 3.31, 0.263, 400, 380, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
537, d6cp4A_, 0.8318, 3.31, 0.263, 400, 380, P450CAM D251N MUTANT
538, d4wg2A1, 0.8318, 2.95, 0.219, 405, 375, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
539, d4ek1A_, 0.8318, 2.96, 0.219, 405, 375, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
540, d3cppA_, 0.8318, 3.02, 0.138, 411, 377, CRYSTAL STRUCTURE OF THE CARBON MONOXY-SUBSTRATE-CYTOCHROME P450-CAM TERNARY COMPLEX
541, d2frzA_, 0.8318, 2.95, 0.213, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
542, d1phbA_, 0.8318, 2.96, 0.216, 405, 375, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
543, d1nooA_, 0.8318, 2.96, 0.216, 407, 375, CYTOCHROME P450-CAM COMPLEXED WITH 5-EXO-HYDROXYCAMPHOR
544, d4wg2C_, 0.8317, 2.96, 0.219, 405, 375, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
545, d4cppA_, 0.8317, 3.04, 0.288, 390, 372, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
546, d1zo4B_, 0.8317, 2.97, 0.216, 405, 375, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
547, d1jmeB_, 0.8317, 3.26, 0.143, 463, 385, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
548, d1iwjA_, 0.8317, 2.96, 0.216, 405, 375, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(109K) CYTOCHROME P450CAM
549, d1akdA_, 0.8317, 3.25, 0.140, 463, 385, CYTOCHROME P450CAM FROM PSEUDOMONAS PUTIDA COMPLEXED WITH 1S-CAMPHOR
550, d3czhA1, 0.8316, 3.23, 0.124, 441, 380, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
551, d2ij3B_, 0.8316, 2.97, 0.216, 404, 375, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
552, d2h7rA_, 0.8316, 3.25, 0.140, 463, 385, L244A MUTANT OF CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
553, d1yqpB_, 0.8316, 2.96, 0.213, 405, 375, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
554, d1p0xB_, 0.8315, 2.97, 0.216, 405, 375, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
555, d1p0wB_, 0.8315, 2.97, 0.216, 404, 375, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
556, d1p0vB_, 0.8315, 2.95, 0.211, 405, 374, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
557, d1gemA_, 0.8315, 2.96, 0.219, 406, 375, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
558, d5e7yA_, 0.8314, 2.97, 0.219, 407, 375, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
559, d4wg2B_, 0.8314, 3.23, 0.118, 455, 380, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
560, d2ij2A_, 0.8314, 3.27, 0.115, 453, 381, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
561, d1c8jA_, 0.8314, 3.24, 0.124, 455, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
562, d3kx4B_, 0.8313, 2.97, 0.213, 405, 375, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
563, d2cppA_, 0.8313, 3.28, 0.121, 452, 381, HIGH-RESOLUTION CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM
564, d2a1oB_, 0.8313, 3.24, 0.124, 457, 380, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
565, d1phgA_, 0.8313, 2.96, 0.219, 405, 374, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
566, d1cp4A_, 0.8313, 2.97, 0.216, 405, 375, FORMATION CRYSTAL STRUCTURE AND REARRANGEMENT OF A CYTOCHROME P450-CAM IRON-PHENYL COMPLEX
567, d4dudA_, 0.8312, 2.97, 0.216, 405, 375, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
568, d4ducA_, 0.8312, 3.11, 0.272, 395, 375, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
569, d5e78A_, 0.8311, 2.98, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
570, d4cp4A_, 0.8311, 2.98, 0.219, 406, 375, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
571, d3wrjA_, 0.8311, 2.39, 0.279, 370, 362, CRYSTAL STRUCTURE OF P450CAM
572, d1t87B_, 0.8311, 3.23, 0.126, 455, 380, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
573, d1phfA_, 0.8311, 2.97, 0.219, 405, 375, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
574, d8cppA_, 0.8310, 3.23, 0.126, 441, 380, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
575, d7cppA_, 0.8310, 2.99, 0.219, 406, 375, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P450(CAM)
576, d4l4cA_, 0.8310, 3.17, 0.173, 463, 382, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
577, d4hgiA_, 0.8309, 3.24, 0.124, 456, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
578, d4hghA_, 0.8309, 2.98, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
579, d3fwgB_, 0.8309, 3.25, 0.124, 457, 380, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
580, d1og5B_, 0.8309, 2.98, 0.213, 405, 375, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
581, d1gekA_, 0.8309, 3.24, 0.118, 456, 380, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
582, p5og9B_, 0.8308, 3.18, 0.154, 461, 382, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
583, d5cppA_, 0.8308, 3.15, 0.128, 471, 383, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P-450(CAM)
584, d3zkpA_, 0.8308, 3.16, 0.131, 478, 383, STRUCTURE OF A MUTANT OF P450 ERYK IN COMPLEX WITH ERYTHROMYCIN B.
585, d3wrmA_, 0.8308, 2.98, 0.213, 405, 375, CRYSTAL STRUCTURE OF P450CAM
586, d3dl9A2, 0.8308, 2.98, 0.216, 407, 375, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
587, d2a1mB_, 0.8308, 2.98, 0.216, 405, 375, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
588, p5og9A_, 0.8307, 3.24, 0.124, 455, 380, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
589, d5lieA_, 0.8307, 3.00, 0.216, 405, 375, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
590, d4nz2A1, 0.8307, 3.00, 0.219, 411, 375, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
591, d4kpbB_, 0.8307, 3.00, 0.219, 411, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
592, d2vn0A_, 0.8307, 3.25, 0.116, 456, 380, CYP2C8DH COMPLEXED WITH TROGLITAZONE
593, d2nnhB_, 0.8307, 2.98, 0.219, 405, 375, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
594, d2ferA_, 0.8307, 2.98, 0.216, 405, 375, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
595, d1lfkA_, 0.8307, 2.99, 0.219, 404, 375, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
596, d2h7sA_, 0.8306, 2.99, 0.213, 405, 375, L244A MUTANT OF CYTOCHROME P450CAM
597, d3c6gA1, 0.8305, 3.25, 0.132, 460, 380, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
598, d2h7sC_, 0.8305, 3.25, 0.132, 460, 380, L244A MUTANT OF CYTOCHROME P450CAM
599, d2qbmA_, 0.8304, 2.98, 0.219, 403, 374, CRYSTAL STRUCTURE OF THE P450CAM G248T MUTANT IN THE CYANIDE BOUND STATE
600, d2ojdA1, 0.8304, 2.98, 0.216, 405, 375,  
601, d1zo4A_, 0.8304, 3.00, 0.216, 405, 375, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
602, d1uyuA_, 0.8304, 2.98, 0.216, 405, 375, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
603, d2ij3A_, 0.8303, 2.99, 0.216, 405, 375, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
604, d1og5A_, 0.8303, 3.24, 0.126, 460, 380, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
605, d2uwhF_, 0.8302, 2.99, 0.216, 405, 375, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
606, d2qboA_, 0.8302, 3.24, 0.124, 457, 380, CRYSTAL STRUCTURE OF THE P450CAM G248V MUTANT IN THE CYANIDE BOUND STATE
607, d2nnbA_, 0.8302, 3.24, 0.124, 441, 380, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
608, d2j1mB_, 0.8302, 2.98, 0.216, 405, 375, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
609, d1phdA_, 0.8302, 2.99, 0.219, 405, 375, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
610, d1og2B_, 0.8302, 3.29, 0.140, 462, 385, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
611, d4r21B_, 0.8301, 3.25, 0.118, 454, 380, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
612, d4i8vB1, 0.8300, 2.98, 0.208, 405, 375, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
613, d4hgjB_, 0.8300, 3.25, 0.124, 441, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
614, d2hpdA_, 0.8300, 3.25, 0.121, 448, 380, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
615, d1jmeA_, 0.8300, 3.25, 0.124, 448, 380, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
616, d5b2vA_, 0.8299, 3.25, 0.121, 444, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
617, d4egmC_, 0.8299, 2.99, 0.216, 405, 375, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
618, d1yqoA_, 0.8299, 3.24, 0.121, 451, 380, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
619, d4hgiB_, 0.8298, 3.26, 0.132, 451, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
620, d4dnzC_, 0.8298, 3.25, 0.121, 450, 380, THE CRYSTAL STRUCTURES OF CYP199A4
621, d2j4sA_, 0.8298, 3.00, 0.219, 405, 375, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
622, d1p0vA_, 0.8298, 3.25, 0.116, 454, 380, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
623, d1dz6A_, 0.8298, 2.99, 0.216, 405, 375, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
624, d5jquA_, 0.8297, 3.00, 0.216, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
625, d2gr6B_, 0.8297, 2.99, 0.213, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
626, d1gjmA_, 0.8297, 2.99, 0.216, 405, 375, COVALENT ATTACHMENT OF AN ELECTROACTIVE SULPHYDRYL REAGENT IN THE ACTIVE SITE OF CYTOCHROME P450CAM
627, p4xrzB_, 0.8296, 3.26, 0.124, 456, 380, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
628, d4hghB_, 0.8296, 3.26, 0.118, 456, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
629, d2qbnA_, 0.8296, 3.27, 0.121, 447, 380, CRYSTAL STRUCTURE OF FERRIC G248V CYTOCHROME P450CAM
630, d2a1nB_, 0.8296, 3.00, 0.216, 405, 375, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
631, d1yqpA_, 0.8296, 3.00, 0.219, 405, 375, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
632, d1p0xA_, 0.8296, 3.00, 0.219, 405, 375, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
633, d1p0wA_, 0.8296, 2.99, 0.216, 405, 375, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
634, d1j51D_, 0.8296, 3.00, 0.219, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
635, d5b2vB_, 0.8295, 2.98, 0.217, 405, 374, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
636, d2jjpA_, 0.8295, 3.00, 0.216, 405, 375, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH INHIBITOR KETOCONAZOLE (KC)
637, d1bu7A_, 0.8295, 3.26, 0.121, 455, 380, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
638, p5ncbA_, 0.8294, 3.26, 0.121, 455, 380, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAIACOL. 
639, d2j1mA_, 0.8294, 3.00, 0.216, 405, 375, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
640, d1fahA_, 0.8294, 3.24, 0.151, 461, 383, STRUCTURE OF CYTOCHROME P450
641, d4nz2B1, 0.8293, 2.99, 0.217, 406, 374, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
642, d4i8vA_, 0.8293, 3.23, 0.126, 454, 380, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
643, d4dtyB_, 0.8293, 3.00, 0.216, 405, 375, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
644, d1j51B_, 0.8293, 3.00, 0.270, 390, 370, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
645, d5jquH_, 0.8292, 3.01, 0.219, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
646, d5dypA_, 0.8292, 3.30, 0.140, 464, 385, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
647, d5b2yA_, 0.8292, 3.30, 0.140, 464, 385, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
648, d4duaB_, 0.8292, 3.01, 0.219, 405, 375, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
649, d3wrlE_, 0.8292, 3.24, 0.121, 454, 380, CRYSTAL STRUCTURE OF P450CAM
650, d1p7rA1, 0.8292, 2.76, 0.299, 379, 368, CRYSTAL STRUCTURE OF REDUCED CO-EXPOSED COMPLEX OF CYTOCHROME P450CAM WITH (S)-(-)-NICOTINE
651, d5jtdA_, 0.8291, 3.18, 0.154, 462, 382, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
652, d2j4sB_, 0.8291, 3.25, 0.129, 444, 380, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
653, d1p2yA1, 0.8291, 3.22, 0.157, 464, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM IN COMPLEX WITH (S)- (-)-NICOTINE
654, d1gebA_, 0.8291, 3.22, 0.157, 464, 382, X-RAY CRYSTAL STRUCTURE AND CATALYTIC PROPERTIES OF THR252ILE MUTANT OF CYTOCHROME P450CAM
655, d4uaxA1, 0.8290, 3.23, 0.157, 463, 382, X-RAY CRYSTAL STRUCTURE OF LIGAND FREE CYP142A2 FROM MYCOBACTERIUM SMEGMATIS
656, d5li6A_, 0.8289, 3.01, 0.219, 405, 375, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
657, d5b2yB_, 0.8289, 2.86, 0.270, 375, 370, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
658, d4zfaA_, 0.8289, 2.98, 0.217, 405, 374, CYTOCHROME P450 WILD TYPE FROM BM3 WITH BOUND PEG
659, d4egoC_, 0.8289, 3.30, 0.140, 462, 385, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
660, d2bmhA_, 0.8289, 2.98, 0.214, 405, 374, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
661, d1mpwB_, 0.8289, 3.01, 0.219, 405, 375, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
662, d4hgjA_, 0.8288, 3.31, 0.140, 463, 385, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
663, d4dufB_, 0.8288, 3.25, 0.124, 456, 380, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
664, d4dtwA_, 0.8288, 3.01, 0.219, 404, 375, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
665, p3tdaC_, 0.8288, 3.25, 0.118, 453, 380, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
666, d3benB_, 0.8288, 3.24, 0.151, 461, 383, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
667, d3benA_, 0.8288, 3.27, 0.126, 458, 380, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
668, d1nr6A1, 0.8288, 3.00, 0.219, 405, 375, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH DICLOFENAC
669, d1n6bA1, 0.8288, 3.24, 0.121, 441, 380, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH A DIMETHYL DERIVATIVE OF SULFAPHENAZOLE
670, d5jqvB_, 0.8287, 3.36, 0.123, 454, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
671, d4gqsC1, 0.8287, 3.00, 0.216, 405, 375, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
672, d4dtwB_, 0.8287, 3.20, 0.154, 461, 382, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
673, p3qm4A_, 0.8287, 3.10, 0.177, 423, 378, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
674, d2nnhA_, 0.8287, 3.10, 0.177, 423, 378, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
675, d1bvyB_, 0.8287, 3.25, 0.130, 471, 385, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
676, d5jtdB_, 0.8286, 3.31, 0.124, 451, 380, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
677, p4j14A_, 0.8286, 3.28, 0.121, 457, 380, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH POSACONAZOLE BOUND
678, d4dtzB_, 0.8286, 3.25, 0.118, 441, 380, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
679, d3kx5A_, 0.8286, 3.30, 0.121, 453, 380, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
680, d5jqvA_, 0.8285, 3.00, 0.207, 393, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
681, d4dubB_, 0.8284, 3.27, 0.118, 441, 380, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
682, d4dtzA_, 0.8284, 3.29, 0.121, 453, 380, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
683, p3tdaA_, 0.8284, 2.94, 0.208, 393, 371, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
684, d5li6B_, 0.8283, 3.26, 0.121, 452, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
685, d4egpB_, 0.8283, 3.26, 0.118, 441, 380, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
686, d3wrjE_, 0.8283, 3.02, 0.216, 404, 375, CRYSTAL STRUCTURE OF P450CAM
687, d2gqxB_, 0.8283, 3.29, 0.118, 452, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
688, d1t88B_, 0.8283, 2.99, 0.211, 405, 374, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
689, d3wrmF_, 0.8282, 3.04, 0.216, 405, 375, CRYSTAL STRUCTURE OF P450CAM
690, d2zujA_, 0.8282, 3.20, 0.155, 458, 381, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT(D297L)
691, d2z97A_, 0.8282, 3.31, 0.121, 455, 380, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 7- METHYL-7-DEPROPIONATED HEMIN
692, d4dtyA_, 0.8281, 3.01, 0.219, 405, 375, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
693, d4do1C_, 0.8281, 3.02, 0.219, 405, 375, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
694, d3wrhE_, 0.8281, 3.26, 0.118, 441, 380, CRYSTAL STRUCTURE OF P450CAM
695, d1pq2A_, 0.8281, 3.26, 0.118, 441, 380, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
696, d5jqvD_, 0.8280, 3.25, 0.118, 441, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
697, d2ve3B_, 0.8280, 3.00, 0.214, 405, 374, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
698, d1yrdA_, 0.8280, 3.28, 0.126, 453, 380, X-RAY CRYSTAL STRUCTURE OF PERDEUTERATED CYTOCHROME P450CAM
699, p6cizB_, 0.8279, 3.20, 0.275, 397, 374, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
700, d4i8vC_, 0.8279, 3.20, 0.275, 397, 374, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
701, d2nnjA_, 0.8279, 3.30, 0.121, 455, 380, CYP2C8DH COMPLEXED WITH FELODIPINE
702, d2nniA_, 0.8279, 2.94, 0.212, 396, 372, CYP2C8DH COMPLEXED WITH MONTELUKAST
703, d1bvyA_, 0.8279, 3.32, 0.124, 454, 380, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
704, p6cizA_, 0.8278, 3.29, 0.118, 455, 380, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
705, p4fiaA_, 0.8278, 3.16, 0.157, 462, 381, CRYSTAL STRUCTURE OF HUMAN CYP46A1 P450 WITH BICALUTAMIDE BOUND
706, d3wspA_, 0.8278, 3.28, 0.127, 477, 386, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
707, d2ij4A_, 0.8278, 3.30, 0.124, 453, 380, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
708, d1dz4A_, 0.8278, 3.00, 0.217, 405, 374, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
709, p6chiB_, 0.8277, 3.33, 0.118, 450, 380, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
710, d4egnC_, 0.8277, 3.30, 0.124, 440, 380, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
711, d3fwiA_, 0.8277, 3.31, 0.121, 452, 380, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND TETRAGONAL CRYSTAL FORM
712, d2zuhA_, 0.8277, 3.28, 0.118, 457, 380, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297A)
713, d2z3tB_, 0.8277, 3.03, 0.219, 405, 375, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
714, p5xa3D_, 0.8276, 3.02, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
715, d4kf2A_, 0.8276, 3.31, 0.124, 458, 380, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
716, d2zwtA_, 0.8276, 3.21, 0.122, 450, 378, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
717, p5xa3A_, 0.8275, 3.02, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
718, d5e9zC1, 0.8275, 3.02, 0.213, 405, 375, CYTOCHROME P450 BM3 MUTANT M11
719, d3cbdA_, 0.8275, 3.00, 0.258, 399, 372, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
720, p6chiA_, 0.8274, 2.71, 0.287, 377, 366, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
721, d4zfbA_, 0.8274, 3.28, 0.126, 452, 380, CYTOCHROME P450 PENTAMUTANT FROM BM3 BOUND TO PALMITIC ACID
722, d3zbyC1, 0.8274, 3.28, 0.124, 460, 380, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
723, d2qblA_, 0.8274, 2.88, 0.208, 393, 370, CRYSTAL STRUCTURE OF FERRIC G248T CYTOCHROME P450CAM
724, d4ejgG_, 0.8273, 3.29, 0.121, 455, 380, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
725, d3zbyF1, 0.8273, 3.04, 0.216, 405, 375, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
726, d3zbyB1, 0.8273, 3.31, 0.124, 448, 380, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
727, d3zbyA1, 0.8273, 3.30, 0.113, 456, 380, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
728, d2p85B_, 0.8273, 3.29, 0.118, 453, 380, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
729, d3zbyD1, 0.8272, 3.11, 0.158, 467, 379, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
730, d3wspB_, 0.8272, 3.32, 0.121, 457, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
731, d2pg5C_, 0.8272, 3.32, 0.121, 454, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
732, d1z11C_, 0.8272, 3.26, 0.146, 461, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
733, d5veuA_, 0.8271, 3.16, 0.150, 461, 381, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
734, d4i8vD_, 0.8271, 3.40, 0.126, 453, 382, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
735, d4ducB_, 0.8271, 3.29, 0.156, 461, 384, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
736, d3zbyE1, 0.8271, 3.30, 0.124, 453, 380, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
737, d3fwjA_, 0.8271, 3.27, 0.160, 465, 382, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND ORTHOROMBIC CRYSTAL FORM
738, d3fwgA_, 0.8271, 3.26, 0.157, 463, 382, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
739, d3cbdB_, 0.8271, 3.15, 0.122, 438, 376, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
740, d2ij4B_, 0.8271, 3.33, 0.121, 458, 380, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
741, d2fdvC_, 0.8271, 3.36, 0.184, 436, 381, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
742, d5b2uB_, 0.8270, 3.36, 0.184, 436, 381, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
743, d4zf8A_, 0.8270, 3.30, 0.118, 453, 380, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND METYRAPONE
744, d4g3rB_, 0.8270, 3.30, 0.121, 455, 380, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
745, d4egoB_, 0.8270, 3.31, 0.118, 453, 380, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
746, d4c9pB_, 0.8270, 3.30, 0.118, 456, 380, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
747, d3fwfB_, 0.8270, 3.30, 0.118, 453, 380, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
748, d2m56A_, 0.8270, 3.12, 0.158, 467, 379, THE STRUCTURE OF THE COMPLEX OF CYTOCHROME P450CAM AND ITS ELECTRON DONOR PUTIDAREDOXIN DETERMINED BY PARAMAGNETIC NMR SPECTROSCOPY
749, d1smiB_, 0.8270, 2.68, 0.288, 376, 365, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
750, d1c8jB_, 0.8270, 2.97, 0.208, 393, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
751, d4ejhE_, 0.8269, 3.05, 0.219, 405, 375, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
752, d2pg7C_, 0.8269, 3.02, 0.211, 405, 374, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
753, d2feuA_, 0.8269, 3.05, 0.219, 405, 375, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
754, d2fdyC_, 0.8269, 3.05, 0.219, 405, 375, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
755, d5vc0A_, 0.8268, 3.04, 0.219, 405, 375, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO RITONAVIR
756, d5jquG_, 0.8268, 3.03, 0.219, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
757, d5jq2A_, 0.8268, 3.29, 0.118, 453, 380, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
758, d4l4cB_, 0.8268, 3.03, 0.207, 393, 372, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
759, d3kx4A_, 0.8268, 3.05, 0.219, 405, 375, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
760, d2fduC_, 0.8268, 3.20, 0.163, 463, 381, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
761, p6chiC_, 0.8267, 3.32, 0.118, 454, 380, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
762, d5xhjB_, 0.8267, 2.89, 0.156, 427, 372, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
763, d4gqsB1, 0.8267, 3.05, 0.216, 405, 375, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
764, d4egoA_, 0.8267, 3.30, 0.159, 458, 384, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
765, p3qm4B_, 0.8267, 3.30, 0.130, 468, 385, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
766, p5xa3C_, 0.8266, 3.26, 0.157, 463, 382, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
767, d5b2uA_, 0.8266, 3.28, 0.154, 463, 383, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
768, d4r21A_, 0.8266, 3.11, 0.122, 439, 376, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
769, d2pg6C_, 0.8266, 3.32, 0.158, 457, 385, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
770, d2fdwC_, 0.8266, 3.33, 0.182, 426, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
771, d1z10C_, 0.8266, 3.33, 0.121, 453, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
772, p6cizC_, 0.8265, 3.29, 0.127, 451, 379, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
773, d5b2xB_, 0.8265, 3.05, 0.219, 404, 375, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
774, d4zf6A_, 0.8265, 3.30, 0.159, 457, 384, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND PEG
775, d4h24A_, 0.8265, 2.89, 0.208, 393, 370, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
776, d2zwuA_, 0.8265, 3.04, 0.211, 405, 375, CRYSTAL STRUCTURE OF CAMPHOR SOAKED FERRIC CYTOCHROME P450CAM
777, d2ve3A_, 0.8265, 3.04, 0.221, 405, 375, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
778, p5xa3B_, 0.8264, 2.76, 0.280, 376, 364, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
779, d5dypC_, 0.8264, 3.32, 0.124, 453, 380, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
780, d2zuiA_, 0.8264, 3.33, 0.126, 451, 380, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297N)
781, d2uwhC_, 0.8264, 3.05, 0.219, 405, 375, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
782, d4c9lB_, 0.8263, 3.33, 0.124, 453, 380, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
783, p3mdvA_, 0.8263, 3.33, 0.132, 444, 380, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
784, p5tftA_, 0.8262, 3.34, 0.123, 455, 381, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
785, d5e9zD_, 0.8262, 3.30, 0.159, 455, 384, CYTOCHROME P450 BM3 MUTANT M11
786, d5e9zA_, 0.8262, 3.39, 0.123, 460, 381, CYTOCHROME P450 BM3 MUTANT M11
787, d3oftC_, 0.8262, 3.09, 0.257, 400, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
788, d3nplB_, 0.8262, 3.06, 0.219, 405, 375, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
789, p3mdvB_, 0.8262, 3.23, 0.173, 463, 382, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
790, d3kx3B_, 0.8262, 3.09, 0.257, 400, 373, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
791, d2frzB_, 0.8262, 3.09, 0.257, 400, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
792, d2fe6A_, 0.8262, 3.09, 0.260, 400, 373, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
793, d1yrcA_, 0.8262, 3.09, 0.260, 400, 373, X-RAY CRYSTAL STRUCTURE OF HYDROGENATED CYTOCHROME P450CAM
794, p6chiD_, 0.8261, 3.16, 0.152, 464, 381, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
795, p4xrzA_, 0.8261, 3.09, 0.257, 400, 373, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
796, d3ebsC_, 0.8261, 3.33, 0.121, 453, 380, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
797, d2zaxA_, 0.8261, 3.17, 0.160, 463, 381, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
798, d2fduD_, 0.8261, 3.17, 0.160, 464, 381, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
799, d1jpzB_, 0.8261, 3.30, 0.141, 462, 382, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
800, d5x23A_, 0.8260, 3.26, 0.125, 467, 383, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT A477T (*30) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
801, d4h24D_, 0.8260, 3.31, 0.118, 456, 380, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
802, d4ejjA_, 0.8260, 3.06, 0.260, 400, 373, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
803, d4ejhC_, 0.8260, 3.06, 0.213, 405, 375, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
804, p3tbgC_, 0.8260, 3.06, 0.216, 404, 375, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
805, d3nplA_, 0.8260, 3.38, 0.126, 455, 381, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
806, p3el3A_, 0.8260, 3.33, 0.121, 455, 380, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
807, d1z11D_, 0.8260, 3.18, 0.160, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
808, p6cizD_, 0.8259, 3.33, 0.124, 453, 380, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
809, d5veuD_, 0.8259, 3.32, 0.129, 460, 380, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
810, d5jqvC_, 0.8259, 3.06, 0.219, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
811, d5e78B_, 0.8259, 2.97, 0.208, 393, 371, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
812, d4kpaA1, 0.8259, 3.15, 0.181, 407, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 IN COMPLEX WITH N- PALMITOYLGLYCINE (NPG)
813, d4ejgE1, 0.8259, 3.05, 0.211, 405, 375, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
814, p3tbgA_, 0.8259, 3.06, 0.219, 404, 375, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
815, d2uwhD_, 0.8259, 3.32, 0.121, 455, 380, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
816, d2pg5D_, 0.8259, 3.06, 0.216, 405, 375, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
817, d1z10D_, 0.8259, 3.16, 0.152, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
818, d4dudB_, 0.8258, 3.15, 0.163, 464, 380, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
819, p3mdtB_, 0.8258, 3.04, 0.219, 404, 374, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
820, d2uwhE_, 0.8258, 3.18, 0.160, 464, 381, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
821, d5veuC_, 0.8257, 3.35, 0.159, 463, 383, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
822, d5jquD_, 0.8257, 3.40, 0.118, 451, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
823, d5jquC_, 0.8257, 3.33, 0.124, 457, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
824, d4h24C_, 0.8257, 3.06, 0.219, 405, 375, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
825, d4dnjA_, 0.8257, 3.25, 0.124, 453, 379, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A2
826, d4c9oB_, 0.8257, 3.21, 0.160, 464, 382, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
827, d4c9kB_, 0.8257, 3.44, 0.161, 465, 386, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
828, d3t3rA_, 0.8257, 3.34, 0.124, 453, 380, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
829, d3m4vA_, 0.8257, 3.33, 0.154, 455, 383, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
830, d3ekfB_, 0.8257, 2.97, 0.208, 393, 371, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
831, d3ekbA_, 0.8257, 3.28, 0.155, 457, 381, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
832, d5yhjB_, 0.8256, 3.36, 0.124, 453, 380, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
833, d5e9zB_, 0.8256, 3.34, 0.124, 453, 380, CYTOCHROME P450 BM3 MUTANT M11
834, p4enhA_, 0.8256, 3.06, 0.176, 422, 375, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH FLUVOXAMINE BOUND
835, d4ejgA_, 0.8256, 3.19, 0.160, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
836, d4c9nA_, 0.8256, 3.21, 0.160, 464, 382, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
837, d4c9mB_, 0.8256, 3.21, 0.160, 464, 382, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
838, d3ofuF_, 0.8256, 3.44, 0.161, 464, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
839, d3ofuE_, 0.8256, 3.34, 0.126, 453, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
840, d2uwhA_, 0.8256, 3.34, 0.129, 460, 380, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
841, d1zo9A_, 0.8256, 3.33, 0.132, 457, 380, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
842, d1smjA_, 0.8256, 3.06, 0.219, 405, 375, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
843, d5veuH_, 0.8255, 3.04, 0.157, 435, 375, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
844, d5ucwA_, 0.8255, 3.04, 0.157, 435, 375, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
845, d5jqvF_, 0.8255, 3.36, 0.124, 453, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
846, p4wnvA_, 0.8255, 3.33, 0.124, 450, 380, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
847, d4ejiA_, 0.8255, 3.06, 0.216, 405, 375, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH TWO MOLECULES OF 4- (METHYLNITROSAMINO)-1-(3-PURIDYL)-1-BUTANONE
848, d4ejgC_, 0.8255, 3.39, 0.121, 458, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
849, d4egnB_, 0.8255, 3.14, 0.184, 407, 375, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
850, d4du2B_, 0.8255, 3.19, 0.186, 424, 377, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
851, d4c9pA_, 0.8255, 3.19, 0.163, 467, 380, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
852, d4c9oA_, 0.8255, 3.31, 0.129, 444, 379, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
853, d3t3qD_, 0.8255, 3.34, 0.132, 452, 380, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
854, d2fdwD_, 0.8255, 2.81, 0.231, 390, 372, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
855, d5veuB_, 0.8254, 3.33, 0.129, 456, 380, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
856, p5e0eA_, 0.8254, 3.19, 0.186, 424, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B37 FROM DESERT WOODRAT IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
857, p4wnwA_, 0.8254, 3.41, 0.123, 456, 381, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
858, d4kpbA_, 0.8254, 3.05, 0.217, 405, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
859, d4kf2B_, 0.8254, 3.06, 0.216, 405, 375, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
860, d4dnzB_, 0.8254, 3.07, 0.219, 405, 375, THE CRYSTAL STRUCTURES OF CYP199A4
861, p3mdrA_, 0.8254, 3.42, 0.161, 456, 385, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
862, d2ij2B_, 0.8254, 3.27, 0.155, 457, 381, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
863, d1fagD_, 0.8254, 3.20, 0.165, 464, 381, STRUCTURE OF CYTOCHROME P450
864, p4nkvB_, 0.8253, 3.07, 0.219, 405, 375, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
865, d4gqsA1, 0.8253, 3.19, 0.163, 464, 381, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
866, d4do1A_, 0.8253, 3.41, 0.123, 458, 381, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
867, d3kx3A_, 0.8253, 3.30, 0.151, 463, 383, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
868, d2pg6D_, 0.8253, 3.41, 0.139, 455, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
869, d1zo9B_, 0.8253, 3.15, 0.168, 465, 380, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
870, d1smjD_, 0.8253, 3.17, 0.152, 464, 381, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
871, d1pq2B_, 0.8253, 3.21, 0.163, 467, 380, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
872, d1fagA_, 0.8253, 3.34, 0.124, 456, 380, STRUCTURE OF CYTOCHROME P450
873, d5jqvE_, 0.8252, 2.76, 0.190, 417, 369, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
874, d5dyzC_, 0.8252, 2.76, 0.190, 417, 369, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
875, d5b2wB_, 0.8252, 3.19, 0.163, 464, 381, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
876, d4egmB_, 0.8252, 3.39, 0.159, 457, 384, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
877, d4do1B_, 0.8252, 3.34, 0.154, 459, 382, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
878, d4c9nB_, 0.8252, 3.32, 0.127, 452, 379, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
879, p3mdrB_, 0.8252, 3.31, 0.124, 454, 380, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
880, d3lxhB_, 0.8252, 3.36, 0.126, 456, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
881, d2zawA_, 0.8252, 3.17, 0.155, 464, 381, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 6- METHYL-6-DEPROPIONATED HEMIN
882, d1jpzA_, 0.8252, 3.21, 0.161, 467, 380, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
883, d5xhjA_, 0.8251, 3.21, 0.161, 467, 380, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
884, p4nkwA_, 0.8251, 3.46, 0.123, 458, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
885, d4kewA_, 0.8251, 3.19, 0.163, 464, 381, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
886, d4egnA_, 0.8251, 3.19, 0.163, 464, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
887, d4dufC_, 0.8251, 3.34, 0.118, 456, 380, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
888, p5kdyA_, 0.8250, 3.25, 0.185, 424, 378, THE CRYSTAL STRUCTURE OF THE D251N MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
889, p4xrzD_, 0.8250, 3.40, 0.126, 458, 381, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
890, d4ruiE1, 0.8250, 3.39, 0.159, 469, 383, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
891, d3lxiB_, 0.8250, 3.32, 0.116, 454, 380, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
892, d2uwhB_, 0.8250, 3.35, 0.118, 453, 380, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
893, d5veuJ_, 0.8249, 3.34, 0.139, 456, 380, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
894, d4ejhD_, 0.8249, 3.03, 0.223, 399, 372, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
895, d4ejhB_, 0.8249, 3.03, 0.223, 399, 372, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
896, d4dueA_, 0.8249, 3.17, 0.184, 407, 375, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
897, d1fagC_, 0.8249, 3.16, 0.184, 407, 375, STRUCTURE OF CYTOCHROME P450
898, p6cirC_, 0.8248, 3.16, 0.166, 463, 380, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
899, d5veuF_, 0.8248, 3.34, 0.121, 451, 380, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
900, p5uysB_, 0.8248, 3.37, 0.124, 452, 380, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
901, d5a5jA1, 0.8248, 3.32, 0.119, 442, 378, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
902, d4ejhA_, 0.8248, 3.19, 0.149, 411, 376, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
903, d4egmA_, 0.8248, 3.19, 0.149, 411, 376, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
904, d4e2pA_, 0.8248, 3.42, 0.131, 451, 381, CRYSTAL STRUCTURE OF A POST-TAILORING HYDROXYLASE (HMTN) INVOLVED IN THE HIMASTATIN BIOSYNTHESIS
905, d4dnzA_, 0.8248, 3.20, 0.183, 426, 377, THE CRYSTAL STRUCTURES OF CYP199A4
906, d4c9lA_, 0.8248, 3.19, 0.155, 464, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
907, d3t3sC_, 0.8248, 3.16, 0.184, 408, 375, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
908, d1zoaB_, 0.8248, 3.17, 0.184, 407, 375, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
909, d1r9oA1, 0.8248, 2.83, 0.239, 390, 372, CRYSTAL STRUCTURE OF P4502C9 WITH FLURBIPROFEN BOUND
910, d1fagB_, 0.8248, 2.87, 0.228, 390, 373, STRUCTURE OF CYTOCHROME P450
911, p5irqC_, 0.8247, 3.41, 0.121, 458, 381, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
912, p4h23A_, 0.8247, 3.36, 0.124, 458, 380, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
913, d4dueB_, 0.8247, 3.40, 0.118, 455, 381, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
914, d4du2A_, 0.8247, 3.33, 0.154, 459, 382, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
915, p5uysC_, 0.8246, 3.38, 0.121, 453, 380, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
916, d5jquF_, 0.8246, 3.37, 0.124, 455, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
917, p4nkvC_, 0.8246, 3.18, 0.158, 464, 379, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
918, p3swzA_, 0.8246, 3.19, 0.154, 464, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
919, d3lxhA_, 0.8246, 3.18, 0.152, 464, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
920, d3ebsD_, 0.8246, 2.99, 0.208, 393, 371, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
921, d1smjB_, 0.8246, 3.44, 0.121, 444, 381, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
922, d5veuG_, 0.8245, 3.16, 0.181, 408, 375, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
923, d5jqvH_, 0.8245, 3.17, 0.184, 408, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
924, d5b2wA_, 0.8245, 3.19, 0.165, 463, 381, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
925, p4xrzC_, 0.8245, 3.20, 0.163, 464, 381, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
926, d4ruiB1, 0.8245, 3.33, 0.152, 458, 382, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
927, p4nkwB_, 0.8245, 3.37, 0.183, 463, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
928, d4dnzD_, 0.8245, 3.24, 0.161, 461, 380, THE CRYSTAL STRUCTURES OF CYP199A4
929, p3mdmA_, 0.8245, 3.26, 0.124, 440, 378, THIOPERAMIDE COMPLEX OF CYTOCHROME P450 46A1
930, d2pg5B1, 0.8245, 3.35, 0.126, 448, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
931, d2j0cC_, 0.8245, 3.00, 0.208, 393, 371,  
932, d2fdvD_, 0.8245, 3.31, 0.185, 427, 379, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
933, d1zoaA_, 0.8245, 3.25, 0.122, 448, 378, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
934, d4o4pB_, 0.8244, 3.42, 0.121, 455, 381, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
935, d2ve4A_, 0.8244, 3.36, 0.156, 456, 385, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
936, d2pg7D_, 0.8244, 3.38, 0.159, 461, 384, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
937, d5kyoB_, 0.8243, 2.99, 0.208, 393, 371, CRYSTAL STRUCTURE OF CYP101J2
938, p5irvC_, 0.8243, 3.42, 0.123, 454, 381, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
939, d4egpA_, 0.8243, 3.20, 0.163, 464, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
940, d4c9kA_, 0.8243, 3.36, 0.124, 458, 380, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
941, d2v0mC1, 0.8243, 3.40, 0.118, 454, 381, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
942, p2q9fA_, 0.8243, 3.26, 0.157, 463, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1 IN COMPLEX WITH CHOLESTEROL-3-SULPHATE
943, d5xxiA_, 0.8242, 3.42, 0.121, 455, 381, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
944, d5x24A_, 0.8242, 3.35, 0.121, 451, 379, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT I359L (*3) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
945, d5jqvG_, 0.8242, 3.33, 0.126, 453, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
946, d4ejjD_, 0.8242, 3.35, 0.126, 452, 380, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
947, d3t3sB_, 0.8242, 2.99, 0.208, 394, 371, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
948, p3rukD_, 0.8242, 2.93, 0.208, 393, 370, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
949, d5yhjA_, 0.8241, 3.17, 0.184, 407, 375, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
950, d4ruiD1, 0.8241, 3.31, 0.185, 425, 379, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
951, p4nkwD_, 0.8241, 3.18, 0.184, 405, 375, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
952, p4nkvA_, 0.8241, 3.08, 0.219, 405, 375, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
953, d4keyA_, 0.8241, 3.36, 0.124, 456, 380, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
954, d4ejjB_, 0.8241, 3.36, 0.124, 453, 380, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
955, d3t3qA_, 0.8241, 3.33, 0.157, 453, 383, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
956, d3m4vB_, 0.8241, 3.33, 0.124, 450, 379, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
957, p2q9gA_, 0.8241, 2.93, 0.208, 393, 370, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1
958, d2fduB_, 0.8241, 3.36, 0.118, 456, 380, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
959, d1smjC_, 0.8241, 3.05, 0.205, 393, 371, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
960, p5uysA_, 0.8240, 3.23, 0.164, 455, 379, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
961, d5l94B_, 0.8240, 3.20, 0.165, 464, 381, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
962, d4k9wC_, 0.8240, 3.18, 0.184, 407, 375, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
963, d4c9mA_, 0.8240, 3.43, 0.121, 458, 381, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
964, d3t3rC_, 0.8240, 3.34, 0.152, 458, 382, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
965, d2pg6B1, 0.8240, 3.19, 0.152, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
966, d4ruiF1, 0.8239, 3.19, 0.152, 464, 381, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
967, p4nkxC_, 0.8239, 3.38, 0.118, 453, 380, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
968, d3t3sD_, 0.8239, 3.43, 0.123, 455, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
969, d3t3qC_, 0.8239, 3.39, 0.159, 461, 384, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
970, d2fdwB1, 0.8239, 3.33, 0.152, 456, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
971, d2fdvB1, 0.8239, 3.31, 0.159, 459, 383, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
972, d5veuI_, 0.8238, 3.39, 0.154, 452, 383, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
973, p5u6wA_, 0.8238, 3.18, 0.147, 464, 381, THE CRYSTAL STRUCTURE OF 4-METHYLAMINOBENZOATE-BOUND CYP199A4 
974, d4ruiA_, 0.8238, 3.00, 0.208, 393, 371, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
975, d4ejgB_, 0.8238, 2.53, 0.264, 370, 360, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
976, p3tdaD_, 0.8238, 2.53, 0.264, 370, 360, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
977, d5jquE_, 0.8237, 3.00, 0.208, 393, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
978, d4egoD_, 0.8237, 3.16, 0.184, 408, 375, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
979, p3rukB_, 0.8237, 3.16, 0.155, 464, 380, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
980, p6cirB_, 0.8236, 3.37, 0.124, 457, 380, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
981, p6cirA_, 0.8236, 3.37, 0.149, 453, 383, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
982, p5irqB_, 0.8236, 3.42, 0.121, 455, 381, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
983, d4k9wA_, 0.8236, 3.39, 0.159, 461, 384, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
984, d4i4gA_, 0.8236, 3.38, 0.126, 454, 380, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO OXAZOLE-SUBSTITUTED DESOXYRITONAVIR
985, d3t3qB_, 0.8236, 3.39, 0.118, 450, 380, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
986, d3lxiA_, 0.8236, 3.45, 0.126, 443, 381, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
987, d1z10B1, 0.8236, 3.39, 0.159, 462, 384, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
988, p5u6uA_, 0.8235, 3.39, 0.123, 455, 381, THE CRYSTAL STRUCTURE OF 4-ETHYLTHIOBENZOATE-BOUND CYP199A4 
989, p5irqA_, 0.8235, 3.39, 0.156, 460, 384, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
990, p4wntA_, 0.8235, 3.35, 0.159, 460, 384, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
991, p4nkyB_, 0.8235, 3.18, 0.184, 408, 375, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
992, p4nkxB_, 0.8235, 3.18, 0.184, 408, 375, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
993, d4k9wD_, 0.8235, 3.17, 0.166, 464, 380, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
994, p4h23B_, 0.8235, 3.35, 0.118, 455, 380, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
995, d4ejjC_, 0.8235, 3.34, 0.152, 455, 382, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
996, p3rukA_, 0.8235, 3.33, 0.121, 450, 379, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
997, d2pg7B1, 0.8235, 3.37, 0.124, 452, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
998, d2fdyD_, 0.8235, 3.22, 0.164, 455, 379, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
999, p5irvB_, 0.8234, 3.17, 0.168, 464, 380, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1000, d3pm0A_, 0.8234, 3.33, 0.157, 453, 383, STRUCTURAL CHARACTERIZATION OF THE COMPLEX BETWEEN ALPHA- NAPHTHOFLAVONE AND HUMAN CYTOCHROME P450 1B1 (CYP1B1)
1001, d1z11B1, 0.8234, 3.01, 0.208, 393, 371, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1002, p5kdbA_, 0.8233, 3.37, 0.184, 435, 380, THE CRYSTAL STRUCTURE OF 4-ISOPROPYLBENZOATE-BOUND CYP199A4
1003, p3tdaB_, 0.8233, 3.19, 0.166, 463, 380, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
1004, p3mdtA_, 0.8233, 3.39, 0.160, 465, 382, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
1005, d2x7yB_, 0.8233, 3.21, 0.163, 464, 381, P450 BM3 F87A IN COMPLEX WITH DMSO
1006, d2fduA_, 0.8233, 3.37, 0.124, 457, 380, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1007, p5irvD_, 0.8232, 3.39, 0.124, 446, 380, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1008, d4ejgD1, 0.8232, 3.11, 0.160, 431, 375, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1009, d3tmzA1, 0.8232, 3.21, 0.168, 464, 381, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH AMLODIPINE
1010, d3t3sA_, 0.8232, 2.99, 0.199, 393, 376, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1011, d1z11A1, 0.8232, 3.43, 0.159, 464, 384, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1012, p5irvA_, 0.8231, 3.43, 0.159, 464, 384, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1013, p6cirD_, 0.8230, 2.94, 0.208, 393, 370, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
1014, p4nkxA_, 0.8230, 3.17, 0.184, 408, 375, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
1015, p5uysD_, 0.8229, 3.37, 0.157, 465, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
1016, d4ruiC_, 0.8229, 3.23, 0.177, 433, 378, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1017, d4keyB_, 0.8229, 3.32, 0.157, 463, 383, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
1018, d4ejhH_, 0.8229, 3.24, 0.160, 463, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1019, d4ejhF_, 0.8229, 3.38, 0.121, 451, 380, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1020, d4egmD_, 0.8229, 3.17, 0.163, 464, 380, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1021, d4do1D_, 0.8229, 3.19, 0.152, 464, 381, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1022, p3swzC_, 0.8229, 3.42, 0.159, 462, 384, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1023, d3fwfA_, 0.8229, 3.16, 0.149, 406, 375, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
1024, d3ebsB1, 0.8229, 3.22, 0.168, 464, 381, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1025, d2pg5A_, 0.8229, 3.42, 0.156, 456, 384, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
1026, p5t6qA_, 0.8228, 3.32, 0.157, 455, 383, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH OCTANE: AN N- ALKANE AND FATTY ACID OMEGA-HYDROXYLASE WITH A COVALENTLY BOUND HEME
1027, d5dyzA_, 0.8228, 3.35, 0.127, 450, 379, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
1028, p3swzB_, 0.8228, 3.22, 0.165, 464, 381, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1029, d2p85E_, 0.8228, 3.21, 0.165, 463, 381, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1030, d2fdwA_, 0.8228, 3.30, 0.121, 438, 379, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1031, p5kt1A_, 0.8227, 3.32, 0.185, 422, 378, THE CRYSTAL STRUCTURE OF 4-METHYLTHIOBENZOATE-BOUND CYP199A4
1032, p4nkyC_, 0.8227, 3.20, 0.163, 463, 380, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1033, d4kewB_, 0.8227, 3.36, 0.118, 455, 380, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
1034, d2fdvA_, 0.8227, 3.36, 0.159, 460, 384, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
1035, d5veuK_, 0.8226, 2.34, 0.281, 360, 356, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1036, d5kyoE_, 0.8226, 3.33, 0.160, 458, 381, CRYSTAL STRUCTURE OF CYP101J2
1037, d4egnD_, 0.8226, 3.19, 0.184, 408, 375, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1038, d3wrkD1, 0.8226, 3.22, 0.163, 463, 381, CRYSTAL STRUCTURE OF P450CAM
1039, d3t3sG_, 0.8226, 3.20, 0.163, 463, 380, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1040, d2ve4B_, 0.8226, 3.22, 0.165, 464, 381, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
1041, d2pg7A_, 0.8226, 3.42, 0.156, 458, 384, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1042, p5irqD_, 0.8225, 3.21, 0.152, 464, 381, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
1043, p4nkyA_, 0.8225, 3.19, 0.166, 463, 380, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1044, p4nkwC_, 0.8225, 3.21, 0.161, 463, 380, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
1045, d4ejgF1, 0.8225, 3.20, 0.166, 463, 380, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1046, d3ua5A1, 0.8225, 3.41, 0.151, 464, 383, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
1047, p4nkvD_, 0.8224, 3.06, 0.202, 393, 371, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
1048, d3t3rB_, 0.8224, 3.22, 0.163, 464, 381, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1049, d5jq2B_, 0.8223, 3.21, 0.152, 464, 381, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
1050, d1z10A_, 0.8223, 3.22, 0.167, 456, 378, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
1051, p4nkyD_, 0.8222, 3.36, 0.119, 451, 379, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1052, p4kq8A_, 0.8222, 2.95, 0.208, 393, 370, STRUCTURE OF RECOMBINANT HUMAN CYTOCHROME P450 AROMATASE
1053, d4ggvA_, 0.8222, 3.32, 0.159, 454, 383, CRYSTAL STRUCTURE OF HMTT INVOLVED IN HIMASTATIN BIOSYNTHESIS
1054, p3swzD_, 0.8222, 3.33, 0.159, 455, 383, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1055, d2p85D_, 0.8222, 3.33, 0.159, 455, 383, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1056, d5kyoA_, 0.8221, 3.35, 0.159, 456, 384, CRYSTAL STRUCTURE OF CYP101J2
1057, p4nkzA_, 0.8221, 3.37, 0.160, 458, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1058, p5k7kA_, 0.8220, 3.31, 0.157, 459, 381, DESIGN AND OPTIMIZATION OF BIARYL ETHER ARYL SULFONAMIDES AS SELECTIVE INHIBITORS OF NAV1.7: DISCOVERY OF CLINICAL CANDIDATE PF-05089771
1059, p5jl9A_, 0.8220, 3.20, 0.163, 463, 380, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #4
1060, d5b2xA_, 0.8220, 3.19, 0.184, 408, 375, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
1061, d3ekfA_, 0.8220, 3.24, 0.165, 463, 381, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
1062, d3dgiA_, 0.8220, 3.06, 0.205, 393, 371, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
1063, p4nkzB_, 0.8219, 3.34, 0.159, 455, 383, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1064, p5jkwA_, 0.8218, 3.34, 0.157, 457, 381, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) COMPLEXED WITH TESTOSTERONE
1065, d4uymA1, 0.8218, 3.34, 0.157, 453, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
1066, d3ebsA_, 0.8218, 3.34, 0.157, 457, 383, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1067, d2x7yA_, 0.8218, 3.35, 0.160, 458, 381, P450 BM3 F87A IN COMPLEX WITH DMSO
1068, d2pg6A_, 0.8218, 3.35, 0.132, 448, 379, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
1069, p5jl7A_, 0.8217, 3.23, 0.168, 464, 381, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #3
1070, p5jl6A_, 0.8217, 3.33, 0.159, 453, 383, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #2
1071, d4h24B_, 0.8217, 3.21, 0.166, 463, 380, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
1072, d5ucwB_, 0.8216, 3.17, 0.161, 464, 380, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
1073, p4nkzC_, 0.8216, 3.35, 0.159, 460, 383, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1074, d4kf0A_, 0.8216, 3.18, 0.116, 459, 380, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
1075, d4ejgH_, 0.8216, 3.18, 0.116, 459, 380, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1076, d3ua5B1, 0.8216, 3.25, 0.163, 463, 381, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
1077, p6b82B_, 0.8215, 3.06, 0.202, 393, 371, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
1078, p4nkxD_, 0.8215, 3.15, 0.167, 456, 377, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
1079, p4l36A_, 0.8215, 3.28, 0.183, 424, 378, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1080, p5kdzA_, 0.8214, 3.33, 0.132, 439, 378, THE CRYSTAL STRUCTURE OF THE T252A MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
1081, p4xryA_, 0.8214, 3.21, 0.163, 465, 380, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1082, d2fdyA_, 0.8214, 3.46, 0.158, 461, 385, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1083, p4wnvC_, 0.8213, 3.20, 0.150, 464, 381, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1084, p4nkzD_, 0.8213, 3.34, 0.158, 462, 380, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1085, d4i4hA_, 0.8213, 3.22, 0.152, 464, 381, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO PYRIDINE-SUBSTITUTED DESOXYRITONAVIR
1086, d3t3rD1, 0.8213, 3.21, 0.163, 465, 380, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1087, p3s7sA_, 0.8213, 3.36, 0.159, 460, 383, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH BREAST CANCER DRUG EXEMESTANE
1088, d2p85C_, 0.8213, 3.42, 0.159, 459, 384, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1089, p5eacA_, 0.8212, 3.35, 0.157, 455, 383, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-TEBUCONAZOLE
1090, d4k9wB_, 0.8212, 3.43, 0.159, 462, 384, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1091, d4hggB_, 0.8212, 3.23, 0.163, 464, 381, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1092, d4d7dA_, 0.8212, 3.28, 0.127, 442, 377, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1093, d4hggA_, 0.8211, 3.24, 0.169, 459, 379, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1094, d3t3sE_, 0.8211, 3.22, 0.152, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1095, p5jkvA_, 0.8209, 3.01, 0.208, 393, 371, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) AT 2.75 ANGSTROM WITH BOUND POLYETHYLENE GLYCOL
1096, p4wmzA_, 0.8209, 2.96, 0.208, 393, 370, S. CEREVISIAE CYP51 COMPLEXED WITH FLUCONAZOLE IN THE ACTIVE SITE
1097, d4rsnB1, 0.8209, 3.42, 0.159, 459, 384, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
1098, d4rsnA1, 0.8209, 3.12, 0.211, 404, 375, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
1099, d4o4pA_, 0.8209, 3.25, 0.165, 464, 381, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
1100, d4hgfA_, 0.8209, 3.21, 0.166, 464, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1101, p3rukC_, 0.8209, 3.36, 0.136, 461, 383, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
1102, p4ze3A_, 0.8208, 3.36, 0.136, 461, 383, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH FLUCONAZOLE
1103, p3s79A_, 0.8208, 3.37, 0.124, 445, 380, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) REFINED AT 2.75 ANGSTROM
1104, p5hs1A_, 0.8206, 3.34, 0.159, 454, 383, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) COMPLEXED WITH VORICONAZOLE
1105, d5a5iA1, 0.8206, 3.23, 0.152, 464, 381, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
1106, d5w0cA1, 0.8205, 3.21, 0.166, 465, 380, CYTOCHROME P450 (CYP) 2C9 TCA007 INHIBITOR COMPLEX
1107, p5uvbA_, 0.8205, 3.07, 0.202, 393, 371, THE CRYSTAL STRUCTURE OF 4-CYCLOPROPYLBENZOATE-BOUND CYP199A4
1108, p4wntB_, 0.8205, 3.37, 0.157, 456, 383, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
1109, p3r1aD_, 0.8205, 3.30, 0.125, 443, 377, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1110, d4hgfB_, 0.8204, 3.22, 0.163, 465, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1111, p4gl5A_, 0.8204, 3.36, 0.155, 458, 381, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG029 (COMPOUND 4)
1112, d4d78A_, 0.8204, 3.05, 0.199, 390, 377, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1113, d2fdyB1, 0.8204, 2.96, 0.208, 393, 370, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1114, p5esnA_, 0.8203, 2.50, 0.227, 390, 362, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT STRUCTURE
1115, p5eseA_, 0.8203, 3.23, 0.160, 464, 381, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73R MUTANT COMPLEXED WITH FLUCONAZOLE
1116, d3t3sF_, 0.8203, 3.14, 0.157, 432, 375, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1117, p3eqmA_, 0.8203, 3.22, 0.163, 464, 380, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE CYTOCHROME P450 IN COMPLEX WITH ANDROSTENEDIONE
1118, p5esjA_, 0.8202, 3.41, 0.159, 454, 383, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH FLUCONAZOLE
1119, p4gl7A_, 0.8202, 3.35, 0.159, 451, 383, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG046 (COMPOUND 5)
1120, d2p85A_, 0.8202, 3.44, 0.156, 456, 384, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1121, p5ul0A_, 0.8201, 3.21, 0.152, 464, 381, S. CEREVISIAE CYP51 COMPLEXED WITH VT-1161
1122, p3r1aH_, 0.8201, 3.49, 0.151, 464, 385, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1123, d5frbA1, 0.8200, 3.40, 0.157, 454, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH A TETRAZOLE-BASED INHIBITOR VT-1598
1124, p5esfA_, 0.8200, 3.21, 0.168, 463, 380, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH FLUCONAZOLE
1125, d4i3qA_, 0.8200, 3.44, 0.126, 459, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 COORDINATED TO A WATER MOLECULE
1126, d3wrkA1, 0.8200, 3.22, 0.163, 465, 380, CRYSTAL STRUCTURE OF P450CAM
1127, d1smiA_, 0.8200, 3.22, 0.163, 465, 380, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
1128, p5d40A_, 0.8198, 3.41, 0.157, 454, 383, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1129, d4kf0B_, 0.8198, 3.44, 0.167, 452, 383, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
1130, d3nxuA_, 0.8198, 3.09, 0.216, 396, 371, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
1131, p4ze2A_, 0.8197, 3.09, 0.216, 396, 371, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH ITRACONAZOLE
1132, p5eagA_, 0.8196, 3.40, 0.159, 455, 383, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR PROCHLORAZ
1133, p5eafA_, 0.8196, 3.21, 0.155, 464, 380, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
1134, p5d3uA_, 0.8196, 3.02, 0.199, 394, 376, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1135, p4lxjA_, 0.8196, 3.02, 0.199, 394, 376, SACCHAROMYCES CEREVISIAE LANOSTEROL 14-ALPHA DEMETHYLASE WITH LANOSTEROL BOUND
1136, p3r1aA_, 0.8196, 3.36, 0.157, 452, 383, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1137, p6cr2B_, 0.8195, 3.44, 0.151, 455, 384, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
1138, p5eskA_, 0.8195, 3.45, 0.167, 452, 383, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH ITRACONAZOLE
1139, p5eadA_, 0.8195, 3.43, 0.121, 453, 380, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-DESTHIO-PROTHIOCONAZOLE
1140, p4ze1A_, 0.8195, 3.34, 0.119, 441, 377, SACCHAROMYCES CEREVISIAE CYP51 Y140F MUTANT COMPLEXED WITH POSACONAZOLE IN THE ACTIVE SITE
1141, p4wnvD_, 0.8195, 3.35, 0.122, 449, 378, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1142, d2q6nB1, 0.8195, 3.29, 0.157, 450, 382, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1143, p3r1aG_, 0.8194, 3.45, 0.167, 452, 383, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1144, d2wuzA_, 0.8194, 3.49, 0.199, 469, 386, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
1145, d3k1oA_, 0.8193, 3.26, 0.171, 465, 381, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH A POTENTIAL ANTICHAGASIC DRUG POSACONAZOLE
1146, p5eahA_, 0.8192, 3.34, 0.124, 437, 378, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR DIFENOCONAZOLE
1147, d4uhlF1, 0.8192, 3.22, 0.163, 465, 380, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1148, p3qi8B_, 0.8192, 3.45, 0.167, 452, 383, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
1149, d2p85F_, 0.8192, 3.44, 0.167, 452, 383, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1150, d2l8mA_, 0.8192, 3.31, 0.138, 452, 377, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1151, d5a1pA_, 0.8191, 3.30, 0.125, 453, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE AND CITRATE
1152, d4uylA1, 0.8191, 3.39, 0.157, 453, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
1153, d1suoA1, 0.8191, 3.43, 0.126, 451, 380, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4 WITH BOUND 4-(4- CHLOROPHENYL)IMIDAZOLE
1154, p5eabA_, 0.8190, 3.20, 0.172, 458, 378, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-TEBUCONAZOLE
1155, d1dt6A1, 0.8190, 3.50, 0.151, 461, 385, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2C5
1156, p4wnvB_, 0.8189, 3.44, 0.154, 470, 383, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1157, p3tbgB_, 0.8189, 3.44, 0.154, 470, 383, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
1158, p3kohB_, 0.8189, 3.43, 0.157, 457, 383, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
1159, d3ibdA1, 0.8189, 3.49, 0.221, 396, 384, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2B6 GENETIC VARIANT IN COMPLEX WITH THE INHIBITOR 4-(4-CHLOROPHENYL)IMIDAZOLE
1160, p5tz1B_, 0.8188, 3.08, 0.199, 393, 371, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
1161, p4wnwB_, 0.8188, 3.23, 0.156, 464, 378, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
1162, p5tftD_, 0.8187, 3.23, 0.163, 465, 380, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1163, d3t3sH_, 0.8187, 3.22, 0.162, 454, 377, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1164, p3r1aC_, 0.8187, 3.42, 0.157, 454, 383, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1165, d3ld6B_, 0.8187, 3.38, 0.160, 457, 381, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
1166, d3i3kB_, 0.8187, 3.24, 0.166, 463, 380,  
1167, p3tbgD_, 0.8186, 3.45, 0.167, 452, 383, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
1168, d3nxuB_, 0.8186, 3.25, 0.157, 464, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
1169, d4r20B1, 0.8185, 3.46, 0.182, 498, 385, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
1170, p5esmA_, 0.8184, 3.38, 0.160, 457, 381, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH FLUCONAZOLE
1171, p5esgA_, 0.8184, 3.44, 0.118, 441, 380, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH ITRACONAZOLE
1172, p4zv8A_, 0.8184, 3.36, 0.157, 458, 381, STRUCTURE OF CYP2B6 (Y226H/K262R) WITH ADDITIONAL MUTATION Y244W IN COMPLEX WITH ALPHA-PINENE
1173, p3kohA_, 0.8184, 3.44, 0.121, 435, 380, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
1174, p5iuzB_, 0.8183, 3.24, 0.155, 464, 381, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
1175, p5tfuD_, 0.8182, 3.46, 0.167, 452, 383, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1176, p3r1aE_, 0.8182, 3.48, 0.184, 496, 385, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1177, d5kyoC_, 0.8181, 3.47, 0.121, 456, 381, CRYSTAL STRUCTURE OF CYP101J2
1178, p5eslA_, 0.8181, 3.47, 0.121, 456, 381, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH ITRACONAZOLE
1179, p5eshA_, 0.8181, 3.44, 0.126, 450, 380, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT IN COMPLEX WITH ITRACONAZOLE
1180, p5eafB_, 0.8181, 3.44, 0.118, 442, 380, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
1181, p4ze0A_, 0.8181, 3.46, 0.159, 461, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH VORICONAZOLE
1182, p4zdzA_, 0.8181, 3.49, 0.184, 496, 385, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH FLUCONAZOLE
1183, p5wbgB_, 0.8180, 3.40, 0.160, 452, 382, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1184, d5vcgA_, 0.8180, 3.52, 0.184, 497, 386, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO BROMOERGOCRYPTINE
1185, d3qu8A1, 0.8180, 3.40, 0.154, 450, 382, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1186, d2q6nA1, 0.8180, 3.28, 0.151, 463, 377, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1187, p5esiA_, 0.8179, 3.10, 0.202, 393, 371, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT
1188, p5e58A_, 0.8179, 3.33, 0.166, 455, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1189, d5ajrA1, 0.8179, 3.29, 0.131, 465, 381, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE 1-TETRAZOLE DERIVATIVE VT-1161 ((R)-2-( 24-DIFLUOROPHENYL)-11-DIFLUORO-3-(1H-TETRAZOL-1-YL)-1-(5- (4-(222-TRIFLUOROETHOXY)PHENYL)PYRIDIN-2-YL)PROPAN-2-OL)
1190, p4xryB_, 0.8179, 3.45, 0.118, 441, 380, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1191, p5eaeA_, 0.8178, 3.40, 0.165, 452, 382, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-DESTHIO-PROTHIOCONAZOLE
1192, d3g1qB_, 0.8178, 3.33, 0.158, 459, 380, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
1193, d6aycA1, 0.8177, 3.25, 0.166, 463, 380, NAEGLERIA FOWLERI CYP51-ITRACONAZOLE COMPLEX
1194, p5v5zA_, 0.8177, 3.47, 0.182, 497, 385, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA ALBICANS
1195, p5tfuB_, 0.8177, 3.53, 0.184, 497, 386, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1196, d3ld6A_, 0.8177, 3.28, 0.155, 464, 381, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
1197, d3i3kA_, 0.8177, 3.40, 0.160, 452, 382,  
1198, p5wbgC_, 0.8176, 3.40, 0.160, 452, 382, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1199, d4uymB1, 0.8175, 3.53, 0.181, 498, 386, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
1200, p3tk3A_, 0.8175, 3.34, 0.171, 452, 381, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1201, p3e6iA_, 0.8175, 3.26, 0.152, 464, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
1202, d2q6nC1, 0.8175, 3.46, 0.187, 497, 384, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1203, p5wbgF_, 0.8174, 3.25, 0.137, 464, 380, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1204, d4uhiD_, 0.8174, 3.44, 0.198, 469, 384, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
1205, p3r1aF_, 0.8174, 3.54, 0.184, 493, 386, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1206, d3jusA_, 0.8174, 3.54, 0.159, 465, 384, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
1207, d2q6nG1, 0.8174, 2.56, 0.224, 389, 362, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1208, d1tqnA_, 0.8174, 3.31, 0.120, 439, 375, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 3A4
1209, p5tfuC_, 0.8173, 3.51, 0.211, 403, 383, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1210, p5iutA_, 0.8173, 3.43, 0.121, 441, 379, STRUCTURE OF P450 2B4 F202W MUTANT
1211, p3tk3C_, 0.8173, 3.39, 0.160, 457, 381, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1212, d2v0mA1, 0.8173, 3.47, 0.185, 497, 384, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1213, d2j0cA_, 0.8173, 3.48, 0.182, 497, 385,  
1214, d3ekdB_, 0.8172, 3.53, 0.181, 498, 386, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
1215, p5e58D_, 0.8171, 3.51, 0.211, 403, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1216, p5e58C_, 0.8171, 3.51, 0.211, 403, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1217, p3tk3B_, 0.8171, 3.47, 0.182, 498, 385, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1218, d3tjsA_, 0.8171, 3.24, 0.137, 465, 380, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN CYTOCHROME P450 3A4 AND DESTHIAZOLYLMETHYLOXYCARBONYL RITONAVIR
1219, p3gphB_, 0.8171, 3.46, 0.197, 469, 385, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
1220, p3e6iB_, 0.8171, 3.49, 0.182, 497, 385, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
1221, p4zdyA_, 0.8170, 3.53, 0.184, 497, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH ITRACONAZOLE
1222, d4uylB1, 0.8170, 3.49, 0.184, 497, 385, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
1223, d4g3jA_, 0.8170, 3.15, 0.168, 453, 376, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
1224, d3dgiB_, 0.8170, 3.28, 0.155, 464, 381, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
1225, p5wbgD_, 0.8169, 3.29, 0.139, 465, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1226, p3tk3D_, 0.8169, 3.23, 0.172, 444, 378, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1227, p5d3uB_, 0.8168, 3.44, 0.157, 442, 381, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1228, d3ekdA_, 0.8168, 3.54, 0.181, 497, 386, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
1229, p5wbgA_, 0.8166, 3.41, 0.160, 442, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1230, d4uhiC_, 0.8166, 3.34, 0.135, 452, 377, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
1231, d4i91A1, 0.8166, 3.29, 0.157, 464, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH ALPHA-PINENE.
1232, p3lc4A_, 0.8166, 3.10, 0.208, 405, 375, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
1233, d3gw9C_, 0.8166, 3.51, 0.161, 465, 384, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
1234, p6cr2A_, 0.8165, 3.54, 0.194, 469, 387, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
1235, p5tz1A_, 0.8165, 3.39, 0.157, 464, 381, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
1236, p3t3zB_, 0.8165, 3.55, 0.184, 495, 386, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1237, p3t3zA_, 0.8165, 3.49, 0.141, 447, 383, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1238, d3hf2B_, 0.8165, 3.20, 0.170, 455, 377, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
1239, d2v0mD1, 0.8165, 3.32, 0.169, 456, 379, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1240, d2j0cD_, 0.8165, 3.27, 0.163, 463, 380,  
1241, p5udaA_, 0.8164, 3.43, 0.144, 462, 382, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
1242, p5eqbA_, 0.8164, 3.56, 0.165, 484, 387, CRYSTAL STRUCTURE OF LANOSTEROL 14-ALPHA DEMETHYLASE WITH INTACT TRANSMEMBRANE DOMAIN BOUND TO ITRACONAZOLE
1243, d2v0mB1, 0.8164, 3.28, 0.153, 452, 378, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1244, d2j0cB_, 0.8164, 3.18, 0.170, 453, 376,  
1245, p5wbgE_, 0.8163, 3.24, 0.155, 464, 380, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1246, p5d40B_, 0.8163, 3.30, 0.136, 465, 381, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1247, d3hf2A_, 0.8163, 3.37, 0.158, 444, 380, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
1248, d4gqsD1, 0.8162, 3.37, 0.158, 444, 380, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
1249, p3me6D_, 0.8162, 3.32, 0.169, 456, 379, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1250, p3me6B_, 0.8162, 3.41, 0.160, 457, 381, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1251, d4uhlA1, 0.8160, 3.12, 0.177, 413, 373, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1252, d4ck8B1, 0.8160, 3.49, 0.182, 497, 385, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
1253, d4ck8A1, 0.8160, 3.51, 0.184, 496, 385, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
1254, d3zg2A_, 0.8159, 3.29, 0.126, 465, 381, STEROL 14 ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR (S)-2-(4-CHLOROPHENYL)-2- (PYRIDIN-3-YL)-1-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL) ETHANONE (EPL-BS1246UDO)
1255, p5tfuA_, 0.8158, 3.30, 0.168, 463, 381, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1256, d5li7A_, 0.8158, 3.41, 0.160, 464, 381, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1257, d4uhlG1, 0.8158, 3.18, 0.170, 453, 376, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1258, p3r1aB_, 0.8158, 3.28, 0.132, 465, 380, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1259, p3me6C_, 0.8158, 2.98, 0.204, 390, 373, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1260, p5uapA_, 0.8157, 3.45, 0.182, 497, 384, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
1261, d5li7B_, 0.8157, 3.55, 0.181, 497, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1262, p5e58E_, 0.8157, 3.55, 0.184, 497, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1263, d4g7gB_, 0.8157, 3.45, 0.182, 498, 384, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
1264, p3t3zD_, 0.8157, 3.46, 0.182, 497, 384, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1265, p3t3zC_, 0.8157, 3.41, 0.139, 464, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1266, d2q6nF1, 0.8157, 3.49, 0.162, 461, 383, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1267, p5uapB_, 0.8156, 3.30, 0.144, 461, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
1268, d4uhlE1, 0.8156, 3.28, 0.132, 464, 380, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1269, p3me6A_, 0.8156, 3.50, 0.182, 498, 385, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1270, d5a1rA_, 0.8155, 3.33, 0.142, 464, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE
1271, p5iuzA_, 0.8154, 3.35, 0.158, 446, 379, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
1272, p4xryD_, 0.8154, 3.15, 0.157, 455, 375, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1273, d4cohB_, 0.8154, 3.56, 0.184, 498, 386, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
1274, d3qu8C1, 0.8154, 3.39, 0.163, 444, 381, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1275, p3e4eA_, 0.8154, 3.23, 0.168, 447, 376, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
1276, p5uecA_, 0.8153, 3.53, 0.171, 488, 385, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH MYRTENYL BROMIDE.
1277, d4uhiA_, 0.8153, 3.14, 0.165, 451, 375, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
1278, d4rrtA_, 0.8153, 3.38, 0.158, 445, 380, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
1279, d3jusB_, 0.8153, 3.38, 0.158, 445, 380, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
1280, d6bd7A_, 0.8151, 3.42, 0.139, 464, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1281, d4uhlC1, 0.8151, 3.54, 0.199, 469, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1282, d4d75A_, 0.8150, 3.42, 0.160, 465, 381, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1283, d3zg3A_, 0.8150, 3.29, 0.161, 462, 380, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR N-(1-(5-( TRIFLUOROMETHYL)(PYRIDIN-2-YL))PIPERIDIN-4YL)-N-(4-( TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-AMINE (EPL-BS967 UDD)
1284, p4wnuC_, 0.8149, 3.35, 0.149, 464, 382, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1285, d4uhlB1, 0.8149, 3.43, 0.134, 464, 381, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1286, p5ufgA_, 0.8148, 3.43, 0.160, 442, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R/I114V) IN COMPLEX WITH MYRTENYL BROMIDE
1287, d3uasA1, 0.8148, 3.33, 0.134, 465, 381, CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR 9-ETHYNYLPHENANTHRENE
1288, p3lc4B_, 0.8148, 3.40, 0.161, 445, 380, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
1289, d4rrtB_, 0.8147, 3.38, 0.152, 464, 381, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
1290, d4rqlB1, 0.8147, 3.56, 0.159, 468, 384, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
1291, d4rqlA1, 0.8147, 3.16, 0.171, 450, 375, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
1292, d6bczA_, 0.8146, 3.55, 0.165, 460, 382, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1293, d3kw4A1, 0.8146, 3.42, 0.157, 465, 381, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG TICLOPIDINE
1294, p3e4eB_, 0.8146, 3.24, 0.159, 455, 377, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
1295, d6ay4A1, 0.8145, 3.24, 0.159, 455, 377, NAEGLERIA FOWLERI CYP51-FLUCONAZOLE COMPLEX
1296, d4uhlH1, 0.8145, 3.46, 0.129, 455, 380, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1297, p5udaB_, 0.8144, 3.33, 0.142, 463, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
1298, p4wnuA_, 0.8144, 3.31, 0.142, 465, 380, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1299, d4c28A_, 0.8144, 3.42, 0.157, 465, 381, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
1300, p5fsaA_, 0.8143, 3.14, 0.157, 449, 375, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
1301, d4k9xA_, 0.8143, 3.30, 0.168, 461, 380, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1302, p6b82A_, 0.8142, 3.32, 0.161, 461, 380, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
1303, d4c27B_, 0.8142, 3.53, 0.182, 497, 385, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
1304, d4c27A_, 0.8142, 3.55, 0.197, 469, 386, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
1305, d5vcdA_, 0.8141, 3.31, 0.166, 448, 380, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO GLYCEROL
1306, d4uhiB_, 0.8141, 3.23, 0.126, 425, 373, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
1307, d4h6oA1, 0.8141, 3.44, 0.134, 464, 381, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE INHIBITOR NEU321 (1-(3-(4-CHLORO-35-DIMETHYLPHENOXY) BENZYL)-1H-IMIDAZOLE
1308, d4k9vA_, 0.8140, 3.43, 0.157, 465, 381, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1309, d4cohA_, 0.8140, 3.55, 0.211, 403, 383, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
1310, d3qoaA1, 0.8140, 3.45, 0.129, 454, 379, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-BENZYLPYRIDINE.
1311, d4bmmB1, 0.8139, 3.43, 0.142, 463, 381, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
1312, p5fsaB_, 0.8138, 3.44, 0.160, 442, 381, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
1313, d3qu8B1, 0.8138, 3.41, 0.134, 464, 381, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1314, p3gphA_, 0.8138, 3.26, 0.164, 460, 379, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
1315, d6bdiA_, 0.8136, 3.32, 0.161, 449, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1316, d3qu8D_, 0.8136, 3.56, 0.197, 469, 386, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1317, d2wuzB_, 0.8136, 3.47, 0.167, 484, 384, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
1318, p4wnuD_, 0.8135, 3.30, 0.168, 464, 380, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1319, d4ckaA1, 0.8135, 3.30, 0.171, 464, 380, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-FLUOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFS)
1320, d6bd5A_, 0.8134, 3.33, 0.131, 423, 375, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1321, p4wnuB_, 0.8134, 3.28, 0.159, 453, 377, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1322, d4bmmA1, 0.8134, 3.28, 0.159, 453, 377, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
1323, d3qu8E1, 0.8134, 3.32, 0.139, 461, 380, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1324, d3nc6B_, 0.8134, 3.51, 0.182, 499, 385, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
1325, d3khmA_, 0.8134, 3.51, 0.182, 499, 385, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH INHIBITOR FLUCONAZOLE
1326, d6bd8A_, 0.8131, 3.26, 0.159, 451, 377, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1327, p5em4A_, 0.8131, 3.26, 0.159, 451, 377, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
1328, d4uhlD1, 0.8131, 3.43, 0.142, 463, 381, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1329, d4ck9A1, 0.8130, 3.55, 0.211, 403, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-CHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFT)
1330, d4c28B_, 0.8130, 3.46, 0.125, 428, 377, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
1331, d4bjkD1, 0.8130, 3.19, 0.162, 451, 376, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1332, p5jlcA_, 0.8129, 3.44, 0.157, 465, 381, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA GLABRATA
1333, p5em4B_, 0.8129, 3.45, 0.157, 465, 381, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
1334, d4jltA1, 0.8129, 3.45, 0.160, 442, 381, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH PAROXETINE
1335, d3l4dB1, 0.8129, 3.37, 0.164, 446, 378, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
1336, d2x2nC_, 0.8127, 3.32, 0.159, 446, 378, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
1337, p4h1nA_, 0.8126, 3.49, 0.155, 449, 381, CRYSTAL STRUCTURE OF P450 2B4 F297A MUTANT IN COMPLEX WITH ANTI- PLATELET DRUG CLOPIDOGREL
1338, d3tikB1, 0.8126, 3.22, 0.160, 451, 375, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
1339, d2x2nD_, 0.8126, 2.79, 0.304, 373, 362, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
1340, d6ay6A1, 0.8125, 3.46, 0.160, 442, 381, NAEGLERIA FOWLERI CYP51-VORICONAZOLE COMPLEX
1341, d3g1qD_, 0.8125, 3.33, 0.134, 465, 381, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
1342, d5vccA_, 0.8124, 3.46, 0.163, 465, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO GLYCEROL
1343, d1w0fA_, 0.8124, 3.43, 0.134, 464, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1344, d3tikC1, 0.8123, 2.75, 0.302, 372, 361, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
1345, d5veuL_, 0.8122, 3.37, 0.139, 462, 381, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1346, d4k9tA_, 0.8121, 3.34, 0.166, 448, 380, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1347, d5kyoD_, 0.8120, 3.32, 0.168, 464, 380, CRYSTAL STRUCTURE OF CYP101J2
1348, p5tftC_, 0.8119, 3.31, 0.168, 464, 380, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1349, d6bd6A_, 0.8118, 3.42, 0.155, 464, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1350, p4xryC_, 0.8117, 3.44, 0.134, 463, 381, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1351, d4bjkC1, 0.8117, 3.39, 0.161, 442, 380, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1352, d3g1qC_, 0.8117, 3.45, 0.163, 465, 381, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
1353, d4g7gD_, 0.8116, 3.59, 0.149, 462, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
1354, d4g7gC_, 0.8116, 3.34, 0.156, 459, 379, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
1355, d3l4dD1, 0.8116, 3.19, 0.158, 452, 374, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
1356, d2wv2A_, 0.8116, 3.42, 0.164, 445, 379, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA BRUCEI IN COMPLEX WITH FLUCONAZOLE
1357, d2q6nE1, 0.8116, 3.41, 0.142, 461, 381, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1358, d2q6nD1, 0.8116, 3.30, 0.164, 461, 379, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1359, d6bdkA_, 0.8115, 3.43, 0.134, 465, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1360, d2x2nA_, 0.8115, 3.46, 0.160, 442, 381, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
1361, d4g3jC_, 0.8114, 3.37, 0.134, 461, 380, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
1362, d3p99C_, 0.8114, 3.38, 0.158, 445, 380, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1363, d3l4dA1, 0.8114, 3.54, 0.159, 462, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
1364, d5vceA_, 0.8112, 3.46, 0.157, 442, 381, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO RITONAVIR
1365, d4d6zA_, 0.8112, 3.56, 0.154, 460, 383, CYTOCHROME P450 3A4 BOUND TO IMIDAZOLE AND AN INHIBITOR
1366, d4bmmD1, 0.8110, 3.31, 0.162, 445, 377, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
1367, d3ua1A_, 0.8110, 3.28, 0.157, 452, 376, CRYSTAL STRUCTURE OF THE CYTOCHROME P4503A4-BROMOERGOCRYPTINE COMPLEX
1368, d3mvrB1, 0.8110, 3.40, 0.155, 442, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
1369, p5e58B_, 0.8108, 3.44, 0.142, 464, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1370, d3mvrA1, 0.8107, 3.41, 0.158, 460, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
1371, d5tl8A1, 0.8106, 3.26, 0.164, 459, 378, NAEGLERIA FOWLERI CYP51-POSACONAZOLE COMPLEX
1372, p4mgjA_, 0.8106, 3.38, 0.134, 461, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 F429H IN COMPLEX WITH 4-CPI
1373, d4g3jD_, 0.8106, 3.46, 0.136, 464, 382, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
1374, d3nc3B_, 0.8106, 3.46, 0.136, 464, 382, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1375, d4bjkB1, 0.8105, 3.45, 0.160, 461, 381, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1376, d3juvA_, 0.8105, 3.50, 0.157, 465, 382, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51)
1377, d4rm4A_, 0.8104, 3.31, 0.161, 461, 379, THE CRYSTAL STRUCTURE OF THE VERSATILE CYTOCHROME P450 ENZYME CYP109B1 FROM BACILLUS SUBTILIS
1378, d2x2nB_, 0.8104, 3.28, 0.162, 448, 376, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
1379, d3p99D_, 0.8103, 3.28, 0.162, 448, 376, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1380, d4ny4A_, 0.8099, 3.41, 0.163, 442, 380, CRYSTAL STRUCTURE OF CYP3A4 IN COMPLEX WITH AN INHIBITOR
1381, d3gw9A_, 0.8098, 3.33, 0.140, 460, 379, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
1382, d3tikA1, 0.8097, 3.22, 0.157, 449, 375, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
1383, d3gw9D_, 0.8097, 3.41, 0.161, 443, 379, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
1384, d3qu8F_, 0.8096, 3.53, 0.164, 484, 385, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1385, p2f9qC_, 0.8096, 3.45, 0.161, 449, 379, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1386, d6bdmA_, 0.8094, 3.48, 0.150, 465, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1387, d4by0A1, 0.8094, 3.34, 0.164, 443, 377, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
1388, d3gw9B_, 0.8094, 3.42, 0.161, 444, 379, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
1389, d3p99A_, 0.8092, 3.48, 0.163, 460, 381, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1390, d4g3jB_, 0.8091, 3.48, 0.157, 442, 381, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
1391, d4r20A_, 0.8090, 3.47, 0.161, 434, 380, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
1392, d3g1qA_, 0.8090, 3.35, 0.161, 456, 378, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
1393, d3l4dC1, 0.8089, 3.38, 0.164, 442, 378, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
1394, d3p99B_, 0.8087, 3.28, 0.138, 459, 378, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1395, d4k9uA_, 0.8086, 3.37, 0.161, 440, 378, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1396, d2lqdA_, 0.8086, 3.55, 0.164, 483, 385, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1397, d6aybA1, 0.8085, 3.27, 0.146, 458, 378, NAEGLERIA FOWLERI CYP51-KETOCONAZOLE COMPLEX
1398, d4bjkA1, 0.8084, 3.39, 0.165, 461, 381, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1399, p2f9qA_, 0.8084, 3.45, 0.160, 462, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1400, d4bmmC1, 0.8081, 3.26, 0.143, 458, 378, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
1401, d4g7gA_, 0.8080, 3.33, 0.165, 444, 376, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
1402, d3nc5A_, 0.8080, 3.28, 0.170, 450, 376, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1403, d2wx2A_, 0.8080, 3.38, 0.161, 431, 378, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
1404, d4by0B1, 0.8076, 3.42, 0.161, 457, 380, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
1405, d3k9yA_, 0.8075, 3.32, 0.167, 453, 377, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
1406, d4uvrA1, 0.8073, 3.38, 0.161, 439, 378, BINDING MODE SELECTIVITY AND POTENCY OF N-INDOLYL- OXOPYRIDINYL-4-AMINO-PROPANYL-BASED INHIBITORS TARGETING TRYPANOSOMA CRUZI CYP51
1407, d3tikD1, 0.8069, 3.27, 0.146, 458, 378, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
1408, p2f9qD_, 0.8069, 3.15, 0.239, 389, 368, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1409, d5kyoF_, 0.8068, 3.15, 0.239, 389, 368, CRYSTAL STRUCTURE OF CYP101J2
1410, p5e58F_, 0.8068, 3.49, 0.164, 441, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1411, d4c0cA1, 0.8063, 3.40, 0.161, 457, 380, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(24-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
1412, d3k9vA_, 0.8063, 3.48, 0.161, 460, 379, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
1413, d4uqhA1, 0.8061, 3.42, 0.163, 442, 380, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(34-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
1414, d5g5jA_, 0.8059, 3.44, 0.161, 431, 379, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO METFORMIN
1415, p2f9qB_, 0.8038, 3.45, 0.158, 441, 379, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1416, d3na1A_, 0.8025, 3.43, 0.158, 441, 379, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
1417, d3na0A_, 0.8024, 3.55, 0.177, 487, 384, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
1418, d5te8A_, 0.8023, 3.48, 0.161, 459, 379, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1419, d3k9yB_, 0.8021, 3.33, 0.162, 457, 377, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
1420, d5veuE_, 0.8020, 3.34, 0.178, 445, 377, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1421, d4tvfA_, 0.8017, 3.37, 0.161, 441, 378, OXYB FROM ACTINOPLANES TEICHOMYCETICUS
1422, d3na0B_, 0.8017, 3.43, 0.159, 459, 378, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
1423, d2vkuA_, 0.8017, 3.42, 0.161, 446, 378, 44 -DIHYDROXYBENZOPHENONE MIMICS STEROL SUBSTRATE IN THE BINDING SITE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) IN THE X-RAY STRUCTURE OF THE COMPLEX
1424, d3n9zA_, 0.8015, 3.43, 0.161, 447, 379, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
1425, d3mzsC_, 0.8015, 3.29, 0.163, 446, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1426, d3k9vB_, 0.8014, 3.35, 0.167, 448, 378, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
1427, d3n9yA_, 0.8013, 3.49, 0.160, 457, 381, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
1428, d3n9yB_, 0.8011, 3.47, 0.158, 459, 379, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
1429, d5te8C_, 0.8010, 3.51, 0.158, 446, 379, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1430, d5te8B_, 0.8010, 3.34, 0.149, 448, 377, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1431, d3na1B_, 0.8010, 3.45, 0.161, 455, 378, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
1432, d3n9zB_, 0.8008, 2.95, 0.189, 384, 370, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
1433, d1w0gA_, 0.8008, 3.13, 0.167, 447, 372, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1434, d3mzsD_, 0.8006, 3.46, 0.161, 457, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1435, d2wx2B1, 0.8005, 3.14, 0.161, 446, 372, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
1436, d3nc3A_, 0.8000, 3.39, 0.159, 447, 378, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1437, d3mzsA_, 0.8000, 3.34, 0.159, 447, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1438, d3mzsB_, 0.7998, 3.41, 0.161, 448, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1439, d2j0dA1, 0.7985, 3.35, 0.175, 448, 378, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
1440, d3kswA_, 0.7971, 3.36, 0.172, 441, 377, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH AN INHIBITOR VNF ((4-(4- CHLOROPHENYL)-N-[2-(1H-IMIDAZOL-1-YL)-1-PHENYLETHYL]BENZAMIDE)
1441, d1io9A_, 0.7969, 3.36, 0.159, 443, 377, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1442, d6bdhA_, 0.7962, 3.39, 0.134, 464, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1443, d4fdhF1, 0.7960, 3.43, 0.155, 464, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1444, d3psxB_, 0.7960, 3.51, 0.160, 461, 381, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
1445, d3nc5B_, 0.7959, 3.34, 0.159, 448, 377, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1446, d4dvqF1, 0.7957, 3.50, 0.161, 448, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1447, d5hiwA1, 0.7956, 3.49, 0.158, 444, 379, SORANGIUM CELLULOSUM SO CE56 CYTOCHROME P450 260B1
1448, p3dskA_, 0.7953, 3.44, 0.187, 445, 379, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
1449, p3dsjA_, 0.7952, 3.54, 0.161, 457, 380, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
1450, p3dsiA_, 0.7952, 3.42, 0.161, 460, 379, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
1451, p2rchA_, 0.7952, 3.53, 0.158, 440, 379, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
1452, p3cliA_, 0.7950, 3.52, 0.150, 456, 380, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
1453, d3nc6A_, 0.7949, 3.52, 0.161, 462, 380, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
1454, p4zgxK_, 0.7948, 3.34, 0.164, 458, 378, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1455, p2rcmA_, 0.7948, 3.53, 0.161, 462, 380, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
1456, d1io7A_, 0.7946, 3.27, 0.168, 446, 374, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1457, d4dvqE1, 0.7943, 3.22, 0.158, 452, 374, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1458, p4zgxB_, 0.7941, 3.42, 0.161, 448, 378, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1459, p2rclA_, 0.7941, 3.02, 0.236, 385, 364, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
1460, p4zgxC_, 0.7938, 3.36, 0.159, 447, 377, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1461, d4fdhE1, 0.7936, 3.42, 0.156, 448, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1462, d4dvqG_, 0.7936, 3.42, 0.156, 448, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1463, d1io8A_, 0.7936, 2.42, 0.302, 364, 354, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1464, d4fdhB_, 0.7935, 2.42, 0.302, 364, 354, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1465, d4fdhG_, 0.7934, 3.43, 0.161, 444, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1466, d3psxA_, 0.7933, 3.49, 0.163, 448, 381, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
1467, d2j0dB1, 0.7932, 3.56, 0.158, 460, 380, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
1468, d4fdhD_, 0.7927, 3.43, 0.161, 450, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1469, d4fdhK_, 0.7925, 3.43, 0.161, 450, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1470, d4fdhA_, 0.7923, 3.38, 0.159, 446, 377, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1471, d4dvqA_, 0.7923, 3.45, 0.172, 449, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1472, p4zgxA_, 0.7922, 3.26, 0.144, 453, 376, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1473, p4zgxD_, 0.7921, 3.51, 0.169, 454, 378, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1474, d4dvqC_, 0.7919, 3.60, 0.160, 456, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1475, d1w0eA_, 0.7919, 3.39, 0.159, 439, 377, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1476, d4dvqH_, 0.7914, 3.57, 0.155, 449, 380, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1477, d4dvqB_, 0.7914, 3.53, 0.163, 448, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1478, p4zgxJ_, 0.7911, 3.57, 0.155, 448, 380, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1479, d4fdhC_, 0.7906, 3.31, 0.180, 406, 373, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1480, d4dvqJ_, 0.7906, 3.43, 0.156, 448, 377, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1481, d3g5nA1, 0.7903, 3.34, 0.188, 444, 377, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1482, p4zgxL_, 0.7902, 3.43, 0.159, 448, 378, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1483, p4zgxF_, 0.7900, 3.31, 0.163, 450, 374, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1484, d4dvqD_, 0.7900, 3.26, 0.209, 405, 374, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1485, d4wqjA_, 0.7898, 3.31, 0.168, 445, 374, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COLLECTED AT 298K AND COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1486, p4zgxE_, 0.7897, 3.38, 0.162, 447, 377, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1487, p4zgxH_, 0.7895, 3.55, 0.172, 454, 379, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1488, d4fdhH_, 0.7894, 3.47, 0.162, 438, 377, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1489, d4tuvA_, 0.7890, 3.58, 0.158, 448, 380, X-RAY CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1490, d4fdhJ_, 0.7890, 2.86, 0.238, 384, 361, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1491, p3dbmA_, 0.7888, 3.65, 0.166, 441, 380, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1492, d4tt5A_, 0.7887, 3.44, 0.159, 440, 378, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1493, d4fdhI_, 0.7886, 3.58, 0.155, 461, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1494, p3danA_, 0.7886, 3.53, 0.158, 436, 379, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1495, p5livD_, 0.7884, 3.37, 0.168, 446, 376, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1496, d3b6hB1, 0.7884, 3.51, 0.172, 451, 377, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
1497, d4dvqI_, 0.7883, 3.01, 0.201, 383, 368, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1498, d1ue8A_, 0.7882, 3.34, 0.159, 457, 377, CRYSTAL STRUCTURE OF THERMOPHILIC CYTOCHROME P450 FROM SULFOLOBUS TOKODAII
1499, p3damA_, 0.7881, 3.56, 0.155, 443, 380, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1500, d3b6hA1, 0.7876, 3.62, 0.152, 464, 381, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
1501, d2iagB1, 0.7875, 3.62, 0.152, 464, 381, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
1502, d4fdhL_, 0.7874, 3.54, 0.156, 439, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1503, d2iagA1, 0.7873, 3.48, 0.160, 452, 376, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
1504, d3b4xA_, 0.7869, 3.41, 0.172, 451, 377, CRYSTAL STRUCTURE ANALYSIS OF SULFOLOBUS TOKODAII STRAIN7 CYTOCHROM P450
1505, d4dvqK_, 0.7866, 3.60, 0.157, 472, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1506, d4dvqL_, 0.7858, 3.60, 0.157, 472, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1507, d1po5A1, 0.7853, 3.60, 0.154, 470, 382, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4
1508, d3g5nB1, 0.7847, 3.56, 0.150, 470, 379, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1509, p2rcmB_, 0.7843, 3.66, 0.157, 462, 381, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
1510, d1f4tB_, 0.7843, 3.36, 0.153, 441, 372, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1511, d1io9B_, 0.7840, 2.47, 0.286, 352, 350, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1512, p4zgxI_, 0.7838, 3.62, 0.160, 470, 382, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1513, p3dskB_, 0.7838, 3.41, 0.173, 444, 375, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
1514, p3dsjB_, 0.7838, 3.61, 0.157, 470, 382, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
1515, d3g5nD1, 0.7837, 3.41, 0.153, 470, 379, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1516, d3g5nC1, 0.7837, 3.68, 0.155, 464, 381, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1517, p3dsiB_, 0.7836, 3.61, 0.154, 471, 382, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
1518, p3cliB_, 0.7834, 3.62, 0.162, 470, 382, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
1519, p2rclB_, 0.7832, 3.53, 0.140, 469, 378, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
1520, p2rchB_, 0.7831, 3.59, 0.163, 471, 380, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
1521, d4wpdA_, 0.7826, 3.59, 0.163, 471, 380, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1522, d1f4tA_, 0.7824, 3.63, 0.157, 471, 382, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1523, d1io7B_, 0.7817, 3.63, 0.162, 470, 382, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1524, d4wpdB_, 0.7815, 3.54, 0.157, 455, 375, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1525, d3b98A_, 0.7812, 3.43, 0.158, 470, 379, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
1526, d1f4uB_, 0.7810, 3.77, 0.164, 440, 379, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1527, d1f4uA_, 0.7810, 2.78, 0.239, 380, 356, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1528, d1io8B_, 0.7809, 3.45, 0.158, 470, 379, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1529, d2rfcC_, 0.7799, 3.43, 0.153, 470, 379, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1530, d3b99A_, 0.7794, 3.38, 0.158, 445, 373, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1531, d2rfcD_, 0.7781, 3.65, 0.164, 444, 379, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1532, d2rfcA_, 0.7781, 2.49, 0.259, 366, 344, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1533, d2bz9B_, 0.7772, 3.23, 0.161, 439, 367, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
1534, d1n97A_, 0.7761, 3.55, 0.159, 463, 378, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
1535, p4r1zA_, 0.7759, 3.22, 0.129, 414, 363, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
1536, d2rfbA_, 0.7754, 2.79, 0.242, 373, 355, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1537, p4r1zB_, 0.7727, 3.56, 0.161, 463, 378, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
1538, d2rfcB_, 0.7724, 3.41, 0.210, 390, 372, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1539, d1n97B_, 0.7716, 3.41, 0.210, 390, 372, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
1540, d1e9xA_, 0.7714, 3.50, 0.129, 466, 371, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4-PHENYLIMIDAZOLE
1541, p6fshD1, 0.7701, 3.50, 0.129, 465, 371, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1542, d2bz9A_, 0.7685, 3.50, 0.129, 466, 371, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
1543, d3daxA1, 0.7680, 3.51, 0.129, 465, 371, CRYSTAL STRUCTURE OF HUMAN CYP7A1
1544, d3v8dA1, 0.7677, 3.53, 0.129, 465, 371, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
1545, d2w0bA_, 0.7674, 2.81, 0.242, 374, 355, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR 3-{[(4- METHYLPHENYL)SULFONYL]AMINO}PROPYL PYRIDIN-4-YLCARBAMATE
1546, d3daxB1, 0.7670, 3.62, 0.161, 461, 379, CRYSTAL STRUCTURE OF HUMAN CYP7A1
1547, p6fshA1, 0.7661, 3.46, 0.124, 465, 370, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1548, p3r1bA1, 0.7661, 2.51, 0.256, 366, 344, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1549, d1x8vA_, 0.7659, 3.60, 0.164, 464, 379, ESTRIOL-BOUND AND LIGAND-FREE STRUCTURES OF STEROL 14ALPHA- DEMETHYLASE (CYP51)
1550, d1ea1A_, 0.7657, 3.62, 0.158, 465, 379, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH FLUCONAZOLE
1551, d2rfbC_, 0.7656, 3.47, 0.124, 465, 370, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1552, d2rfbB_, 0.7650, 3.62, 0.158, 465, 379, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1553, d3sn5A1, 0.7646, 3.65, 0.163, 464, 380, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
1554, d3v8dB1, 0.7633, 3.57, 0.161, 462, 378, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
1555, p6fshB1, 0.7631, 2.53, 0.256, 366, 344, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1556, d1u13A_, 0.7623, 3.63, 0.164, 465, 379, CRYSTAL STRUCTURE ANALYSIS OF THE C37L/C151T/C442A-TRIPLE MUTANT OF CYP51 FROM MYCOBACTERIUM TUBERCULOSIS
1557, d3b98B_, 0.7622, 3.64, 0.158, 463, 380, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
1558, p6fshC1, 0.7615, 3.29, 0.138, 412, 363, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1559, d1wiyB_, 0.7610, 3.28, 0.160, 441, 368, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1560, d3sn5B_, 0.7607, 3.60, 0.167, 465, 378, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
1561, d1wiyA_, 0.7596, 3.56, 0.162, 469, 377, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1562, d1h5zA_, 0.7569, 3.56, 0.162, 469, 377, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN FERRIC LOW-SPIN STATE
1563, d2bdmA2, 0.7552, 3.64, 0.164, 463, 379, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND BIFONAZOLE
1564, d2w09A_, 0.7528, 3.69, 0.161, 463, 380, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR CIS-4- METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4- YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE
1565, d2w0aA_, 0.7494, 3.55, 0.164, 465, 377, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR N-[(1S)-2-METHYL-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL] CYCLOHEXANECARBOXAMIDE
1566, d3b99B_, 0.7472, 3.56, 0.162, 465, 377, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1567, d2ci0A_, 0.7461, 3.61, 0.161, 462, 378, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
1568, d2cibA_, 0.7460, 3.50, 0.159, 450, 370, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
1569, p5mnvD1, 0.7216, 3.65, 0.161, 462, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1570, d5bv5A_, 0.7166, 3.66, 0.164, 463, 379, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1571, d5bv5D_, 0.7141, 3.57, 0.156, 463, 377, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1572, p5mnvF1, 0.7103, 3.63, 0.161, 462, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1573, p5mnsE1, 0.7064, 3.56, 0.165, 462, 376, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1574, p5mnvC1, 0.7060, 3.73, 0.167, 454, 372, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1575, p5mnsC1, 0.7055, 3.64, 0.161, 462, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1576, p5mnsD1, 0.7032, 3.63, 0.161, 464, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1577, p5mnvE1, 0.6980, 3.70, 0.164, 462, 379, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1578, p3wvsA1, 0.6977, 2.36, 0.260, 367, 339, CRYSTAL STRUCTURE OF CYTOCHROME P450REVI
1579, p2vz7B1, 0.6977, 3.54, 0.155, 459, 375, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1580, p2vz7A1, 0.6965, 3.67, 0.164, 465, 379, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1581, d5bv5C_, 0.6947, 3.66, 0.164, 462, 378, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1582, p4oqrA1, 0.6879, 2.38, 0.260, 367, 339, STRUCTURE OF A CYP105AS1 MUTANT IN COMPLEX WITH COMPACTIN
1583, p4l0eA2, 0.6865, 3.64, 0.162, 462, 377, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (HEME-COORDINATED EXPRESSION TAG)
1584, p3be0A1, 0.6819, 3.61, 0.111, 467, 370, THE ROLE OF ASN 242 IN P450CIN
1585, p5yswA1, 0.6798, 2.39, 0.260, 367, 339, CRYSTAL STRUCTURE ANALYSIS OF RIF16 IN COMPLEX WITH R-L 
1586, p6bldA1, 0.6776, 3.58, 0.162, 462, 376, MYCOBACTERIUM MARINUM CYTOCHROME P450 CYP268A2 IN COMPLEX WITH PSEUDOIONONE
1587, p3qi8A1, 0.6749, 3.64, 0.113, 473, 371, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
1588, p5ysmA1, 0.6679, 3.64, 0.113, 473, 371, CRYSTAL STRUCTURE ANALYSIS OF RIF16 
1589, p4tpoA1, 0.6652, 3.45, 0.215, 389, 367, HIGH-RESOLUTION STRUCTURE OF TXTE WITH BOUND TRYPTOPHAN SUBSTRATE
1590, p4l36B1, 0.6619, 3.45, 0.215, 389, 367, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1591, p3be0B1, 0.6610, 3.63, 0.123, 469, 374, THE ROLE OF ASN 242 IN P450CIN
1592, p5u6tA1, 0.6605, 3.68, 0.164, 462, 378, THE CRYSTAL STRUCTURE OF 4-ETHOXYBENZOATE-BOUND CYP199A4 
1593, p3bdzB1, 0.6579, 2.51, 0.246, 367, 341, THE ROLE OF ASN 242 IN P450CIN
1594, p5ex8A2, 0.6572, 3.59, 0.111, 467, 370, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; ETHYLENE GLYCOL CRYO
1595, p4fmxA1, 0.6569, 3.71, 0.125, 468, 375, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
1596, p5ex9A2, 0.6566, 3.64, 0.120, 466, 374, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; GLYCEROL CRYO
1597, p4fyzA1, 0.6562, 3.58, 0.160, 456, 375, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
1598, p4lhtA1, 0.6561, 3.61, 0.120, 470, 374, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
1599, p3bdzA1, 0.6560, 3.61, 0.120, 470, 374, THE ROLE OF ASN 242 IN P450CIN
1600, p4fmxB1, 0.6559, 2.45, 0.238, 367, 340, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
1601, p4l77B1, 0.6558, 3.63, 0.162, 460, 376, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
1602, p4lhtB1, 0.6557, 3.49, 0.156, 454, 372, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
1603, p4l77A1, 0.6554, 3.83, 0.151, 464, 377, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
1604, p1t2bA1, 0.6552, 3.61, 0.168, 450, 368, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
1605, p4fyzB1, 0.6550, 3.68, 0.119, 465, 369, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
1606, p4l6gB1, 0.6548, 2.58, 0.259, 367, 340, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
1607, p4l6gA1, 0.6546, 2.28, 0.259, 354, 336, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
1608, p1t2bB1, 0.6544, 3.57, 0.155, 458, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
1609, p5omuA1, 0.6521, 3.70, 0.119, 465, 369, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH SYRINGOL 
1610, p3g93A1, 0.6510, 3.73, 0.122, 465, 370, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1611, p4tpnA1, 0.6499, 3.59, 0.168, 450, 368, HIGH-RESOLUTION STRUCTURE OF TXTE IN THE ABSENCE OF SUBSTRATE
1612, p5tftB1, 0.6483, 3.74, 0.165, 451, 369, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1613, p4fb2D1, 0.6482, 3.73, 0.122, 465, 370, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1614, p4fb2A1, 0.6479, 3.74, 0.122, 465, 370, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1615, p5livB1, 0.6451, 3.74, 0.122, 465, 370, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1616, p4fb2B1, 0.6450, 3.74, 0.122, 465, 370, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1617, p4fb2C1, 0.6428, 2.60, 0.256, 367, 340, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1618, p5xw2A1, 0.6427, 2.61, 0.259, 367, 340, CRYSTAL STRUCTURE OF THE HYDROXYLASE HMTN IN C 1 2 1 CRYSTAL FORM 
1619, p5livC1, 0.6420, 2.61, 0.259, 367, 340, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1620, p2yjnB_, 0.6418, 2.61, 0.256, 359, 340, STRUCTURE OF THE GLYCOSYLTRANSFERASE ERYCIII FROM THE ERYTHROMYCIN BIOSYNTHETIC PATHWAY IN COMPLEX WITH ITS ACTIVATING PARTNER ERYCII
1621, p6f8aB1, 0.6415, 2.51, 0.257, 367, 339, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1622, p6f8cA1, 0.6413, 3.80, 0.146, 446, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1623, p6f85B1, 0.6411, 3.80, 0.146, 446, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
1624, p6f88A1, 0.6398, 2.45, 0.258, 366, 337, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
1625, p5xntA1, 0.6376, 2.45, 0.258, 366, 337, STRUCTURE OF CYP106A2 FROM BACILLUS SP. PAMC 23377
1626, p6f8cB1, 0.6368, 2.54, 0.257, 359, 339, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1627, p3g93C1, 0.6365, 2.30, 0.247, 338, 336, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1628, p6f8aA1, 0.6350, 3.87, 0.143, 445, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1629, p3g93D1, 0.6334, 2.32, 0.247, 338, 336, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1630, p5livA1, 0.6329, 2.35, 0.241, 338, 336, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1631, p3r1bC1, 0.6263, 3.46, 0.175, 432, 365, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1632, p3nc7B1, 0.6184, 3.09, 0.154, 385, 351, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1633, p3nc7A1, 0.6102, 3.09, 0.154, 385, 351, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1634, p3g93B1, 0.6062, 3.13, 0.164, 417, 353, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1635, p3r1bB1, 0.6057, 2.43, 0.250, 338, 336, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1636, p3r1bD1, 0.6043, 2.43, 0.250, 338, 336, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1637, p5bv5B1, 0.5726, 3.24, 0.164, 411, 354, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1638, p4zgxG4, 0.5143, 2.47, 0.244, 338, 336, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
